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GENERAL ABSTRACT:
The purpose of this work is two-part. The primary goal of this thesis is to identify a list of significant target insulin­
like peptides (ILPs) that influence the maintenance of neuronal morphology in an aged animal model of 
Caenorhabditis elegans (C. elegans) and determine whether or not morphological changes have bearing on neuronal 
function. The second goal is to address and devise a solution for a common laboratory difficulty encountered within 
the research community, difficulty maintaining large age-synchronous populations of the model organism, C. 
elegans.
Chapter 1 discusses the importance of insulin signaling and how it pertains to the morphology of aging neurons. A 
reverse genetic screen was conducted to knockdown the expression of individual ILPs in a C. elegans model. The 
results identify a subfamily of ILPs that play significant roles in maintaining regular morphology of aging 
mechanosensory neurons. These data corroborate previously published work demonstrating that aberrant 
morphology of mechanosensory neurons does not directly influence their function and that these two parameters, 
morphology and function, can be uncoupled and considered mutually exclusive.
Chapter 2 describes a main difficulty associated with using C. elegans as a model organism; the problem of 
maintaining a large age-synchronous population on solid media. To address this difficulty a novel piece of 
equipment, named the Caenorhabditis Sieve, and an accompanying methodology for its application, were created to 
mechanically sort and clean C. elegans. The use of this new device facilitates the implementation of assays with 
animals cultivated on solid media that are normally cost and resource prohibitive. Presented with the protocol for 
device construction and implementation, are standard experiments that were conducted to verify “proof of concept” 
of the tool's efficacy. The results demonstrate that the Caenorhabditis Sieve effectively transfers animals from one 
culture plate to the next in a manner that does not influence common markers of physiological stress; thus validating 
the sieve's use in future experiments among the research community, as well as highlighting the success of creating 
a cost-effective, efficient, fast, and simple process to mitigate difficulties and ease progress in research fields using 
small model organisms.
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GENERAL INTRODUCTION:
Insulin Ligands Influence Morphology of Mechanosensory Neurons
Aging human brain tissue is subject to normal restructuring over time, and this overall restructuring has been 
proposed as an underlying cause of cognitive decline with advancing age and neurodegeneration1-4. This brain 
restructuring comprises synapse deterioration, neuronal sprouting and restructuring with little if any cell loss, and 
this restructuring is seen as a normal age-related occurrence1-3. Outside of normal, healthy, aging of brain tissue, 
there are neurodegenerative diseases such as Alzheimer's disease (AD), which affects over 5 million Americans5, 
Parkinson's disease (PD), affecting almost 1 million Americans6, and Amyotrophic Lateral Sclerosis (ALS), 
affecting 30,000 Americans7. These diseases are age-related with all three, on average, being diagnosed in subjects 
over 50 years of age5-8. These case numbers are projected to increase as modern medicine progresses and geriatric 
population numbers continue to grow5-8. Under the neurodegenerative conditions of these diseases, an increase in 
protein mis-folding is observed and causes cellular stress, eventually leading to protein aggregation in brain tissue9. 
Over time this cellular stress and protein aggregation can lead to morphology changes in brain structures, atrophy, 
and degeneration in the affected regions10.
A major regulator of the aging process, both at the organismal and cellular levels, is the insulin and insulin-like 
signaling (IIS) pathway, which influences lifespan, health quality, and life stage progression11,12. This pathway is 
conserved in metazoans ranging from Drosophila13 to humans and in the latter, a single nucleotide polymorphism 
(SNP) of the FOXO transcription factor (DAF-16 in Caenorhabditis elegans (C. elegans)), an insulin signaling 
target, can help predict whether an individual will reach the age of 100 years14. This IIS pathway has also been 
shown to influence neuronal morphology in a C. elegans model15-17, yet no correlation has been found between the 
number of neuronal morphological changes linked to the IIS pathway modulation and changes in neuronal function 
or lifespan17. Interestingly, these morphological changes at the neuronal level appear to be independent from neuron 
function and organismal lifespan.
Understanding IIS and its influence on the morphology of healthy, normal, aging neurons, helps build a foundation 
of knowledge that can be used to understand IIS in age-related neurodegenerative conditions. By establishing a 
baseline for the morphological changes seen in healthy brains and neurons, researchers can reference a metric to 
compare neurodegenerative conditions. This is important because of the projected increase in age-related 
neurodegenerative conditions that will parallel the increase in the geriatric population5-8. Understanding IIS in 
healthy neurons is important also because neurodegenerative conditions such as AD have been correlated with 
dysregulation of normal insulin and insulin-like growth factor expression in the central nervous system (CNS) of 
humans18,19. Indeed, some researchers have proposed a relatively new “type III” diabetes to reflect the 
neurodegenerative pathogenesis seen in AD patients19. If neurodegeneration can be triggered over time in what is 
thought to be healthy, non-disease carrying individuals, then prevention, mitigation and possible reversal are all the 
more important. Others have already shown that gain of function mutations in IIS pathway constituents in models 
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where their respective upstream activator molecules are missing can help to recover dysregulated signaling20-22. 
Thus, this is a potentially fruitful route to explore therapeutic targets.
The nematode worm C. elegans is a premier model organism whose genome has been fully sequenced23. The 
cellular fate of all 959 cells has also been mapped in the C. elegans hermaphrodite, including its 302 neurons24.25. 
Because of its ease of culturing, relatively quick life cycle and simplified nature of complex tissues like intestine, 
reproductive, and nervous systems, C. elegans is a common model system for the study of aging, molecular 
pathways and neurodegeneration26-31. A key feature for C. elegans use in aging studies is that it utilizes the 
previously mentioned conserved IIS pathway for cellular signaling with 40 species specific insulin-like peptides 
(ILPs)32. While humans produce 10 ILPs and rely on a vascular system for intercellular insulin transportation, C. 
elegans secretes some 40 ILPs primarily from neurons32-25. These ILPs affect neighboring cells, or diffuse into a 
fluid-filled body cavity called a “pseudocoelom” that bathes C. elegans tissues and organs and serves to function in 
place of a respiratory and circulatory system for cases outside of local cell-to-cell secretion and signaling36-38.
Currently the IIS pathway has been mapped with respect to its major participants and targets28,30,32,39. The structure 
of both the insulin ligands and the insulin receptor (IR), a receptor tyrosine kinase (RTK) are known, as well as the 
specific binding sites on the receptor and the general mechanism that induces conformation change upon ligand 
binding which allows for tyrosine phosphorylation of substrate40,41. The IIS pathway, as depicted by Murphy and 
Hu, comprises the ILP ligands, the IR (DAF-2 in C. elegans), primary messengers such as AGE-1 and 
phosphoinositide-3 kinases (PI3), secondary messengers such as PDK-1 and AKT-1, and transcription factors HSF- 
1, DAF-16/FoxO, and SKN-1/Nrf (Figure I.1)32.
Upon agonist ligand binding at the IR, the IIS pathway is activated which results in the phosphorylation of pro­
longevity transcription factors HSF-1, DAF-16, and SKN-1. Phosphorylation of these transcription factors inhibits 
their translocation to the nucleus, where they function to upregulate downstream pro-longevity genes. Antagonist 
ligand binding at the receptor or other resultant decrease in IR activity would have the opposite effect and cause a 
“disinhibition” of the transcription factors, allowing them to translocate to the cell nucleus and activate pro­
longevity genes30,32,39.
The insulin ligands themselves are peptide ligands composed entirely of amino acids with two major functional 
domains, the A and B peptide domains34,42. These A and B peptide regions are α helices and give ILPs a basic helix­
loop-helix folded structure34,40-42. In addition to this basic structure, the known ILPs have been subdivided into three 
major subfamilies based on their sequence and structural similarity, the a, p, and y subfamilies34,42. The y subfamily 
is characterized by canonical disulfide bonds found in mammalian and most all other insulin ligands, and the a 
subfamily by nonpolar substitutions at the 6/11 disulfide bond positions on the A peptide35. The p subfamily is 
characterized by the three canonical di-sulfide bonds found in mammalian and most other insulin ligands, as well as 
additional di-sulfide bonds at position 21 of the A peptide and position 22, 23, or 24 of the B peptide34 (Figure
2
I.2)36. These minor alterations in sequence and conserved intra-subfamily sequence variation between ILPs produces 
subtle changes in structure and variations in the affinity of ILPs for the IR and other interacting molecules43. These 
variations may also influence the ILPs' immediate agonist/antagonist action at the IR's binding sites as the relative 
binding affinities of ILPs and their immediate binding roles as either agonist or antagonist are still largely unknown. 
In fact, agonist or antagonist activity is not conserved across ILP subfamilies with both activities seen in a given 
subfamily34,44-46. Several researchers have investigated the agonistic and antagonistic roles of ILP function in C. 
elegans models but have done so with endpoint-specific results that did not utilize local intra-IIS pathway 
constituents. The agonistic/antagonistic role of individual ILPs was determined by downstream endpoints such as 
dauer arrest (a larval stage diapause)34,35,37,44,46,47, olfactory learning45, downstream marker regulation37,46, or ILP-to- 
ILP interactions28,45,46, to name a few. Additionally, different tissues and developmental time points can vary the 
specific ILPs present and their expression levels35,37,48. While incredibly insightful, these studies do not focus on 
ligand/receptor activation or blocking at the molecular level, albeit a more difficult operation considering the many 
ILPs present in the C. elegans model. These variations in ILP sequence, conformation and potential binding affinity 
have led to beliefs of functionally redundant ILPs in cases of compromised expression of an individual ILP34,35,37,49 
and/or that different subfamilies and each individual ILP has different roles and expression patterns based on given 
environmental and metabolic stress conditions35,47.
The IR is a homodimer with each monomer consisting of three main regions, an extracellular domain, 
transmembrane domain, and a cytosolic domain40,41. As represented by Colin Ward, the extracellular domains are 
shaped in “upside down Vs” that, when dimerized through disulfide bonds, rest side-by-side against one another, 
facing 180 degrees opposite the other with eclipsed side silhouettes (Figure I.3)40. Each monomer has a primary 
binding site (S1) for ILPs on the distal V arm and a secondary, weaker, region that binds ILPs on the V arm 
proximal to the transmembrane region (S2), meaning that each side of the IR's extracellular domain has a primary 
binding site (S1) and a secondary site on the opposing IR monomer (S2') that lies next to it40,41. Upon ILP binding to 
a primary (S1) IR site, the IR dimers are rotated together to allow the ILP's secondary site to bind the opposing 
monomer's complimentary secondary site (S2')40-41. This is illustrated by Colin Ward as a two-step action that 
occurs on either side of the IR's extracellular region (Figure I.4)40. This rotation causes a conformational change 
through the transmembrane region that leads to an unrolling of coiled tyrosine kinase (TK) regions on the cytosolic 
region of the IR homodimers (Figure I.3)40. This IR dimer rotation also pulls the other set of primary and secondary 
ILP binding regions apart on the opposing side of the IR's extracellular domain (Figure I.4)40. When the TK regions 
unwind, there are thirteen potential phosphorylation sites along each cytosolic domain of the IR. These docking sites 
are thought to be for SH2 and PTB-domain containing proteins, which are signal and RNA binding proteins, 
respectively40.
While the vast majority of the research conducted to date investigates the pathway itself and its primary downstream 
constituents, there has been relatively limited research conducted on the signaling molecules upstream of the IR that 
bind and activate it in regards to neuronal aging processes. In C. elegans, many studies have been conducted with 
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individual ILPs to ascertain the effects of their absence or overexpression in specific tissues or on specific 
events34,44-46, but collective studies on the ILP family as a whole have been limited. These studies concentrate 
primarily on the expression interactions ILPs have on one another and the relative spatiotemporal expression of each 
in a nematode model35,47,48, or on protein aggregation regulators in disease models31. The specific ligands and the 
phenotypic growth they regulate in neurons are still unclear. Furthermore, the classification of ILPs into 
subfamilies34,42 has not been investigated for correlation with phenotypic regulation. By correlating specific ILPs or 
a particular ILP subfamily with neuronal morphology phenotypes, researchers may be able to use those ILP 
expression levels and actions in neurons to gauge neuronal health and neurodegeneration, and additionally use them 
to build a baseline metric for neurodegenerative conditions when seeking therapeutic treatments.
The objective of Chapter 1 was to modulate the IIS pathway in an aged C. elegans model, via individual knockdown 
of 39 of the 40 ILP ligands expressed, to identify key ILPs responsible for maintaining neuronal morphology and 
function with the hypothesis that the different efficacies within the ILP families will dictate their regulatory 
importance on the neuronal aging process. Results were expected to point to similar ILPs, relative to 
sequence/structure as being important players in this role. The intent was to use the identified ILPs and potential 
findings to contribute to the greater understanding of healthy neuronal aging and use this to seek therapeutic targets 
that are within, or modulatory to, the IIS pathway or the upstream ILP ligands and their expression to help regulate 
or correct any dysregulation of the pathway that could lead to irregular neuronal aging and neurodegeneration.
Caenorhabditis Sieve: A Low-Tech Instrument and Methodology for Sorting Small Multicellular Organisms 
Chapter 2 introduces the development of a novel laboratory tool designed to sort C. elegans and other small 
organisms by body size. This endeavor grew out of the identification of difficulties in maintaining age synchronous 
populations of C. elegans during previous work on ILPs influence on neuronal morphology and identifying these 
same difficulties in the work of others within the C. elegans research community. Many assays require large 
numbers of age synchronous populations to be maintained to prolonged time points (e.g., DNA extraction, RNA 
extraction, lifespan and other age-dependent experiments such as those involving neurodegeneration).
Previous protocols that separate or sort C. elegans by body size have been related to utilizing liquid culture media 
and have unknown outcomes on animal health and stress50. Culturing C. elegans in liquid media has its own specific 
requirements compared to culturing with solid nematode growth media (NGM)27. The liquid conditions require 
closer monitoring as starvation and overcrowding are common and can lead to dauer formation, an arrested 
developmental stage during the Larval 3 growth phase27.
Culturing C. elegans on solid NGM on the other hand requires less monitoring, and allows for harvest and 
separation of specific individual animals for assays such as gentle touch response27,51. The drawback of solid NGM 
is the limited surface area/volume available which limits the number of animals that can be sustained on a single 
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plate before starvation and overcrowding occurs. This requires that animals be cultured on larger and larger plates or 
multiple plates per group to achieve an appropriate population size if large numbers of animals are required for a 
given assay.
When the food supply runs low, C. elegans must be transferred to new plates to maintain environmental 
conditions27. This becomes problematic when multiple generations of animals at different life stages are mixed on 
the NGM plates. Current methods of sorting animals are picking by hand, fluorodeoxyuridine (FUDR) dissolved in 
NGM, and microfluidic sorting. Picking by hand is very accurate but time consuming and inefficient when 
transferring large numbers of animals on multiple plates per group with multiple groups per experiment. FUDR, a 
chemical that inhibits cell proliferation, is toxic, and can lead to possible epigenetic contamination of animals. 
Furthermore, its use is limited to adult animals52-56. Microfluidic sorting utilizes machines with fine capillary tubes 
and optical data processing to sort animals57. These microfluidic methods require that animals be prepared in fluid 
and run through the microfluidic devices. While accurate, it is a complex method that relies on advanced technology 
and the microfluidic channels can become clogged with debris58. In addition to their complexity, microfluidic 
devices can be cost prohibitive to many research groups.
The goal of work reported in Chapter 2 was to create an efficient, fast, affordable, simple to make and simple to 
use/learn device to assist in common laboratory experiments by sorting C. elegans and/or other small organismal 
models by body size. The device and protocol created aimed to teach the scientific community how to manufacture 
and implement such a device to maximize the yield of return on animals sorted and exhibit its efficacy as a safe 
alternative to several current sorting methods.
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FIGURES:
Figure 1.1. Insulin and insulin-like signaling (IIS) pathway 
in C. elegans. Graphic from Murphy and Hu, 2013 (Figure 
l)32. Insulin-like peptides (black circles) bind to the extracel­
lular domain of the DAF-2 receptor located in the cellular 
membrane. Intracellular pathway constituents that promote 
positive IIS signaling are colored red, and pathway constitu­
ents that antagonize or are antagonized by positive IIS signal­
ing are colored green. Agonist binding to the DAF-2 receptor 
functions to inhibit translocation into the nucleus (indicated 
by the dotted line) of the pro-longevity transcription factors 
HSF-1, DAF-16, and SKN-1, while antagonist binding to the 
DAF-2 receptor functions to dis-inhibit their translocation.
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Figure 1.2. Caenorhanditis elegans ILP sub-family distribution. Graphic from Matsunaga 
et al., 2017 (figure 1 )36. Categorization of the 40 C. elegans ILPs into a, p, and γ sub-families. 
Colored blocks represent peptide sequences and black bars represent structural disulfide bonds.
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Figure 1.3. Insulin receptor structure and con­
formational change. Graphic from Ward, Menting 
and Lawrence, 2013 (Figure 5A)40. Insulin recep­
tor (IR) structure shown in side-view in the inactivat­
ed and activated conformations. Upon ligand binding 
to complementary binding regions on the extracel­
lular domain, the cytosolic receptor tyrosine ki­
nase (RTK) unrolls to allow for substrate docking.
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Figure 1.4. ILP binding and disassociation at complimen­
tary homodimer binding sites. Graphic from Ward, Menting, 
and Lawrence, 2013 (Figure l)40. Top view illustration of ILP 
binding at the insulin receptor. ILP (black circle) binds at the 
SI site and triggers crosslinking to S2’ site of adjacent mono­
mer. Dashed arrows depict alternate association and disasso­
ciation routes for the same S1 and S2’ pair. This association and 
dissociation model can occur at the S2 and S1’ sites as well.
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CHAPTER 1:
Insulin Ligands Influence Morphology of Mechanosensory Neurons1
1 Citation: Hunter, S., Vayndorf, E., Driscoll, M., Taylor, B.E., Bult-Ito, A. Insulin ligands influence morphology of
mechanosensory neurons. Manuscript completed in preparation for submittal.
1.1 ABSTRACT:
Insulin signaling plays a key role in the aging of organisms ranging from yeast to mice, and there is evidence that in 
humans, single nucleotide polymorphisms (SNPs) of the insulin transcription factor, FOXO, can predict whether an 
individual will reach the age of 100. In Caenorhabditis elegans (C. elegans), insulin-like peptides (ILPs) are 
regulators of both organismal and neuronal aging. In humans, healthy neuronal aging is characterized by neuronal 
sprouting, synaptic deterioration and restructuring with little to no neuronal cell loss. However, the physiological 
factors that affect the decline of neuronal morphology and structure over time in their native context remain poorly 
understood. This is particularly true at the single cell level. C. elegans ILPs belong to three major subfamilies based 
on their sequence and structure. The goal of this study was to determine how ILPs, individually or as a group, 
influence the morphology of aging mechanosensory neurons. To investigate the relationship between ILPs and 
neuronal morphology and function, a reverse genetic screen of insulin ligands in C. elegans with fluorescently 
labeled mechanosensory neurons was conducted. RNAi was used to individually knock down expression of insulins 
1 through 38 and DAF-28, and structural and functional data were collected for anterior lateral mechanosensory 
(ALM) and posterior lateral mechanosensory (PLM) neurons. ILPs of interest were rescreened for a total of three 
replicates compared to empty vector controls. The results highlight ILPs whose absence correlated with specific 
neuronal aberrations and functional outcomes, and showed that neuronal morphology may be influenced by ILPs in 
a subfamily dependent manner. Specifically, the p subfamily may be particularly important in producing somatic 
outgrowths seen in normal neuronal morphology. The results also agree with previous research that demonstrated 
neuronal morphology aberrations were not influential on functional capacity, in that no relationship was seen 
between neuronal aberration occurrence and mechanosensory neuron function. These data implicate a subfamily of 
ILPs and their ensuing IIS pathway response as possible therapeutic targets in the fight against aging and 
neurodegeneration.
1.2 INTRODUCTION:
Aging related diseases are numerous, many of which are neurodegenerative. Currently 5 million Americans have 
Alzheimer's disease (AD)1, almost 1 million have Parkinson's disease (PD)2, and almost 30,000 have Amyotrophic 
Lateral Sclerosis (ALS)3. These diseases are age-related with all three, on average, being diagnosed over the age of 
50 years1-4. These incidences of these diseases are projected to increase as modern medicine progresses and geriatric 
population numbers continue to grow.
Aging of healthy brains is characterized by neuronal sprouting, synaptic deterioration and restructuring with little to 
no cell loss5. As neurons age there is an increase in the occurrence of this cellular restructuring5,6. Similar to this 
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age-related brain restructuring in humans, the nematode worm Caenorhabditis elegans (C. elegans) exhibits 
structural aging in neurons without cell loss6-8. This structural aging in C. elegans neurons resolves as morphological 
aberrations in the form of new somatic, axonal, and dendritic branching6 The insulin and insulin-like signaling (IIS) 
pathway, a conserved receptor tyrosine kinase pathway among metazoans, has a definitive role in influencing the 
aging processes of C. elegans, impacting lifespan, health quality reporters such as motility, metabolism and stress 
response, as well as life stage progression9-11. The primary components of this pathway in C. elegans, as depicted by 
Scerbak et al.12, comprise the insulin and insulin-like peptide (ILPs) ligands, the insulin receptor DAF-2, primary 
messenger AGE-1, phosphoinositide-3 kinases, secondary messengers AKT-1/AKT-2 and the transcription factor 
DAF-16 (Figure 1.1)12. Under normal operation, positive DAF-2 signaling functionally inhibits the translocation of 
pro-longevity transcription factor DAF-16. This conserved pathway is important to most organisms including other 
nematodes, Drosophila13 and even humans. In the latter, a single nucleotide polymorphism (SNP) of the FOXO 
transcription factor (DAF-16 in C. elegans), an insulin signaling target, can predict whether an individual will reach 
the age of 100 years14.
Modulation of the IIS pathway has been shown to influence the occurrence of age-related neuronal aberrations in C. 
elegans mechanosensory neurons6-8. Reduced IIS pathway activity through knockdown of the sole known insulin 
receptor in C. elegans, DAF-2, has been shown to decrease the occurrence of neuronal aberrations, while 
knockdown of the DAF-2 downstream target DAF-16 (FOXO in humans), a pro-longevity transcription factor, 
results in an increase in these aberrations6,8. In addition to regulating neuronal aberrancy, the IIS pathway plays a 
role in neuronal synapse development and axon regeneration. Decreasing the activity of the DAF-2 receptor reduces 
the occurrence of aberrant synaptic development in motor neurons15 and causes an increase in axon regeneration 
levels after laser ablation16. Modulation of the IIS pathway also influences lifespan, with DAF-2 receptor 
suppression increasing lifespan and DAF-16 transcription factor suppression decreasing lifespan6,8,16. Interestingly, 
the role the IIS pathway plays in neuronal morphology and remodeling and its role in lifespan operate 
independently. The influence exhibited by the IIS pathway on both the occurrence of neuronal aberrations and level 
of axon regeneration are not coupled with lifespan, neuronal morphology and lifespan display a heterogeneity in 
occurrence that makes them independent of one another6,8. The presence of neuronal aberrations in C. elegans 
mechanosensory neurons also does not indicate any influence in their function, meaning that these two metrics 
appear to operate independently as well6.
Because the IIS pathway is so involved in multiple facets of the aging process, the role ILPs binding DAF-2 play in 
neuronal aging was investigated. C. elegans have 40 ILPs; INS-1 through INS-39 and DAF-2817,18. These ILPs have 
been grouped into three major subfamilies, α, β and γ, based on their sequence and structure17,19.
While several genetic screens against C. elegans ILPs have been conducted, they pertain primarily to the ILP-to-ILP 
interactions and relationships and ILP expression levels. These previous screens encompass all 40 C. elegans ILPs 
but do not investigate the morphological outcomes on neurons when ILPs are knocked down. Prior screens have 
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focused on using the dauer phenotype to determine ILP function, spatiotemporal expression patterns of ILPs in 
different tissues at set developmental time-points20,21, or whole animal ILP mRNA expression over only the first 60 
h after embryo hatching22. Researchers have conducted genome-wide RNAi screens in C. elegans searching for 
regulators of polyglutamine aggregation in neurodegenerative models23, but currently no genetic screens have been 
conducted that focus on the roles individual ILPs have on neuronal morphology in healthy models. To investigate 
the roles ILPs play in the neuronal aging process, a reverse genetic screen of 39 of 40 C. elegans ILPs using RNAi 
was conducted, with the hypothesis that knockdown of similar ILP subfamily members will result in similar 
phenotypic aberrations in neurons. This is based on the similar sequence and structure within the insulin 
subfamilies17,19 and the possibility of similar binding affinities and redundancy within subfamilies.
1.3 MATERIALS AND METHODS:
1.3.1 C. elegans strain and maintenance
The strain used in this study, P GFP, P SID-1, P YFP, P mec-6 known as mec-4::gfp, was created by 
mec-4 unc-119 unc-119 mec-6
Dr. Elena Vayndorf in the laboratory of Dr. Monica Driscoll at Rutgers University, New Jersey. This mec-4::gfp 
strain has green fluorescent protein (GFP) expressed in the mechanosensory neurons allowing for whole neuron 
visualization under fluorescent microscopy, and contains neuronal SID-1 channels that allow for dsRNA uptake. 
Standard methods to maintain and manipulate a mec-4::gfp population of C. elegans were used24. The stock 
population was cultured at 25°C on Nematode Growth Media (NGM) agar plates (1 L NGM: 2.5 g peptone, 17 g 
agar, 3 g NaCl, 975 mL double distilled water, 1 mL 5 mg/mL cholesterol, 1 mL 1 M CaCl2, 1 mL 1 M MgSO4, 25 
mL 1 M KHPO4, and 0.5 mL 100 mg/mL streptomycin) seeded with live bacteria (E. coli strain OP50-1) cultured in 
Luria Broth with 100 mg/mL streptomycin that were allowed to form a lawn for 48 h at room temperature and then 
stored at 4°C until use, as per the standard Wormbook protocol25. The stock population was maintained at 25°C 
through at least 3 generations of offspring without starvation, mitigating the effects of environmental stress on gene 
expression. All age-synchronous C. elegans populations were created using the egg lay method , i.e., allowing 20-30 
gravid adults to lay eggs for 4-6 h, then removing the adults, and were cultured at 25°C until day 5 of adulthood26.
Maintaining C. elegans at 25°C is well known to accelerate metabolism and the aging process27-31 as is evidenced by 
the decrease in the gentle touch response32. This accelerated aging process through growth at 25°C better simulates 
an aging model for the purposes of age-related neurodegeneration, as it allows researchers to advance animal age at 
specific time points in comparison to growth at 20°C. Day 5 of adulthood for C. elegans was chosen as a designated 
time point for animal harvesting and data collection in all following assays as apparent differences in touch response 
and neuronal morphology has previously been shown to occur by day 4 of adulthood in C. elegans when matured at 
20°C and maintained at 24°C6.
1.3.2 RNAi plate making
Once a stock population had been obtained and stabilized, RNAi treatment plates were made as per the Wormbook 
protocol33 (1 L NGM: 2.5 g peptone, 17 g agar, 3 g NaCl, 975 mL double distilled water, 1 mL 5 mg/mL 
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cholesterol, 1 mL 1 M CaCl2, 1 mL 1 M MgSO4, 25 mL 1 M KHPO4, 0.5 mL 50 mg/mL carbenicillin, and 1 mL 
1M isopropyl β-D-1-thiogalactopyranoside (IPTG)). Bacterial cultures were established for each RNAi treatment 
clone of E. coli strain HT115 via the Wormbook protocol25. HT115 is a strain used to contain the plasmid vector 
L4440. Each treatment clone has an L4440 plasmid that produces dsRNA for a single target ILP's mRNA. Bacterial 
cultures were inoculated in 15 mL tubes and incubated overnight in Luria Broth with 100 mg/mL carbenicillin. 
RNAi plates were seeded with a micropipette under sterile technique with 200 μL of live treatment bacteria. After 
seeding, RNAi plates were allowed to form a lawn for 48 h at 25°C and then stored at 4°C until use. 48 h prior to 
use, RNAi plates were brought back to 25°C to allow the bacteria to produce fresh dsRNA32.
1.3.3 Ageing acceleration and L4440 vector validation
The temperature accelerated aging process was confirmed along with validation that the L4440 plasmid did not 
influence mechanosensory neuron morphology or function. To verify the effects of temperature and the validity of 
the HT115 strain containing the L4440 vector, RNAi plates with an L4440 empty vector clone, producing no 
dsRNA, were seeded. Two populations of mec-4::gfp animals were age-synchronized and maintained on NGM 
plates at 20°C and two populations on NGM plates at 25°C, for a total of four groups. At the L4 stage two groups 
were transferred to new OP50-1 NGM plates, one at 20°C and one at 25°C. The other two groups were transferred to 
RNAi plates seeded with the L4440 clone, one group maintained at 20°C and the other at 25°C. At day 3 of 
adulthood all groups were transferred to new respective plates and maintained at their respective temperatures. On 
day 5 of adulthood, 30 animals from all four groups were tested for their anterior and posterior gentle touch response 
with two-way analysis of variance (ANOVA) with α = 0.05 followed by a Bonferroni multiple comparison post-test 
with a = 0.05. Animals were then harvested for fluorescent imaging to compare mechanosensory neuron 
morphology. Anterior and posterior morphology aberrations per animal were combined to create a “total anterior 
aberrations” and “total posterior aberrations” categories to achieve a more normal data distribution than seen when 
analyzing individual aberration types and to consolidate multiple individual control analysis. These same four 
groups were compared using a two-way ANOVA with a = 0.05 followed by a Bonferroni multiple comparison post-
test with a = 0.05.
1.3.4 RNAi arrival to mechanosensory neurons
To verify that RNAi treatments were arriving at and influencing the mechanosensory neurons, an RNAi clone 
specifically targeting a mechanosensory neuron gene was used. Several RNAi plates were seeded with the L4440 
vector, and several plates were seeded with an HT115 mec-7 clone, this is a clone containing an L4440 plasmid that 
produces dsRNA targeting the mec-7 gene, a gene required for proper mechanosensory neuron function34-37, and two 
populations were age-synchronized onto NGM both at 25°C. Groups were grown normally until the L4 stage. At the 
L4 stage animals were transferred to L4440 or mec-7 treatment plates. At day 3 of adulthood, both groups were 
transferred to new plates with their respective treatments, upon day 5 of adulthood 15 to 20 animals from both 
groups were assayed for the anterior and posterior gentle touch response. The mean anterior and posterior responses 
of the L4440 empty vector control and mec-7 knockdown were compared using a two-tailed T-test with a=0.05.
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1.3.5 RNAi screen
ILP treatment groups were age-synchronized by conducting egg lays from the stock population of mec-4::gfp onto 
NGM plates at 25°C as described above26. Synchronized eggs were allowed to hatch and grow normally until the L4 
stage. Once the L4 stage was reached, 40 animals from each synchronized treatment group were transferred to an 
RNAi treatment plate using an eyelash pick. Eyelash picks consisted of a sterilized hair bonded to the end of a glass 
pipet that allowed for gentle transfer of worms38,39. L4 worms were maintained on the same RNAi treatment plate 
until day 3 of adulthood at which time they were transferred to a new RNAi treatment plate, via eye-lash pick, to 
avoid starvation. On day 5 of adulthood, 30 animals were harvested for fluorescent imaging to compare 
mechanosensory neuron morphology. After statistical analysis of fluorescent imaging, RNAi clone treatments 
producing significant results were DNA sequenced (Supplementary Table 1.5) and repeated two more times for a 
total of three individual replicates per each initial significant RNAi treatment. The touch response data were 
collected on each animal for the subsequent rescreens of ILPs of interest with statistical analysis conducted using a 
one-way ANOVA with a = 0.05 and Dunnett's post-test with a = 0.05 to compare both anterior and posterior touch 
response of RNAi treatments to L4440 control. A second frozen batch of mec-4::gfp animals, due to the time 
separation between the first and second rounds was thawed and used for the rescreening rounds of RNAi.
1.3.6 Fluorescent imaging of mechanosensory neuron morphology
Animals were harvested with an eye-lash pick and mounted to a cover slip on 1μL of 36% pluronic solution. 
Mounted animals were then sandwiched between another cover slip and mounted to a standard glass microscopy 
slide before being placed in an Olympus FSX100 fluorescent microscope. Animals were viewed using a FITC filter 
with 20x magnification and approximately 1/15 s of exposure. Four neurons were evaluated per worm, the two 
Anterior Lateral Mechanosensory (ALM) and the two Posterior Lateral Mechanosensory (PLM) neurons. Neuron 
evaluation consisted of counting and tallying a list of predetermined morphological aberration categories for each 
neuron. These categories were Somatic Outgrowths, Extended Somatic Outgrowths and Neurite Branches (Figure 
1.2). Somatic Outgrowths are processes extending from the cell soma independently from the primary axon/neurite, 
Extended Somatic Outgrowths are Somatic Outgrowths that are at least 2x the length of the cell soma from which 
they originate, and Neurite Branches are atypical processes that extend from the primary axon/neurite6,32. 
Morphological aberrations data were collected in a scaled count for Somatic Outgrowth, Extended Somatic 
Outgrowth and Neurite Branches categories. Mechanosensory neurons were segregated as either anterior or 
posterior, giving two anterior and two posterior neurons per animal, for total anterior and posterior neuron sample 
sizes of two times the number of animals used per treatment group. Comparison of RNAi induced morphological 
aberrations was analyzed using a Kruskal-Wallis test with a = 0.05 followed by a Dunn's multiple comparison post­
test with a = 0.1 in each Somatic Outgrowths', Extended Somatic Outgrowths' and Neurite Branches' anterior and 
posterior categories (a = 0.1 was used to reduce type II errors due to raw data values being smaller than expected 
and right skewed with Poisson distribution).
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1.3.7 Touch Response
The gentle touch response was performed based on the methods described by Calixto et al.38.The anterior and 
posterior touch response was recorded by gently stroking an eyelash pick perpendicularly across the head or tail (5 
times each, alternating head and tail) of the animals. Halting or movement in the opposite direction of the stroke 
earned the animal a point and each animal's response was scored on a scale of 0 to 5 for both anterior and posterior 
response.
1.3.8 Relationship between neuronal morphology and function
For RNAi screen replicates 2 and 3, where both aberration and touch response data was collected, Spearman 
correlation was utilized to search for a relationship between neuronal aberration occurrences and mechanosensation 
capacities. A two-tailed Spearman correlation was performed to determine a Spearman correlation coefficient (rs) for 
the mean occurrence of morphology aberrations versus mean anterior and posterior gentle touch response of each 
RNAi knockdown treatment.
1.4 RESULTS:
1.4.1 Ageing acceleration and L4440 vector validation
To verify accelerated aging of the C. elegans model when maintained at 25°C, and that the L4440 plasmid vector 
did not influence the function of mechanosensory neurons, both anterior and posterior gentle touch response of four 
treatment groups, fed either OP50-1 or L4440 and maintained at both 20°C and 25°C, were compared using two­
way ANOVA. The anterior touch response was significantly depressed in animals reared at 25°C relative to those 
reared at 20°C (p = 0.000, DFn = 1, DFd = 116, F = 13.36). Food source, OP50-1 or L4440, had no influence on 
anterior touch response (p = 0.491, DFn = 1, DFd = 116, F = 0.478) (Figure 1.3A). Animals reared at 25°C had no 
significant change in posterior touch response when compared to those reared at 20°C (p = 0.731, DFn = 1, DFd = 
116, F = 0.119), but L4440 as a food source did produce a decrease in posterior gentle touch response when 
compared to OP50-1 as a food source (p = 0.017, DFn = 1, DFd = 116, F = 5.824) (Figure 1.3B).
To validate that the L4440 plasmid vector did not influence the morphological structure of mechanosensory neurons, 
the occurrence of morphological aberrations in animals at day 5 of adulthood, fed and maintained on OP50-1 were 
compared to animals fed the L4440 RNAi clone, at both 20°C and 25°C. Animal rearing at 25°C had no influence 
on anterior neuronal aberration occurrence when compared to rearing at 20°C (p = 0.157, DFn = 1, DFd = 116, F = 
2.03) and L4440 as a food source had no influence on anterior total aberration occurrence when compared to OP50- 
1 as a food source (p = 0.601, DFn = 1, DFd = 116, F = 0.28) (Figure 1.4A). Animal rearing at 25°C resulted in a 
significant increase in posterior neuronal aberration occurrence when compared to rearing at 20°C (p = 0.003, DFn 
= 1, DFd = 116, F = 9.06) and L4440 as a food source had no influence on posterior neuronal aberration occurrence 
when compared to OP50-1 as a food source (p = 0.489, DFn = 1, DFd = 116, F = 0.48) (Figure 1.4B).
16
1.4.2 RNAi arrival to mechanosensory neurons
To verify that the RNAi was arriving at and influencing the four mechanosensory neurons of interest, the anterior 
and posterior gentle touch response of animals treated with a mec-7 RNAi clone was compared to animals treated 
with the L4440 empty vector RNAi clone. There were statistically significant decreases in both the anterior (p = 
0.0022, t = 3.371, df = 28) and posterior (p = 0.004, t = 3.098, df = 28) gentle touch responses from the mec-7 
treatment group when compared to the L4440 control group (Figure 1.5), thus, showing that the RNAi treatment 
process was effective at targeting and knocking down genes of interest.
1.4.3 RNAi screen
The RNAi screen of 39 of 40 C. elegans ILPs was conducted in a three-part fashion to narrow in on ligands of 
interest. The first round was a screen of ins-1 through ins-38 and daf-28 (an ins-39 RNAi clone was not available). 
After this initial round was completed, knockdown targets that resulted in significant changes in the occurrence of 
morphological aberrations were chosen for RNAi clone sequencing and two more rounds of repeat screening for 
validation.
The initial round of RNAi screening resulted in eight ILPs that showed significant differences in aberrant neuronal 
morphology when compared to the L4440 control; ins-1, ins-2, ins-3, ins-4, ins-9, ins-16, ins-30, and ins-38 (Table 
1.1). The knockdown of ins-1, ins-4, and ins-30 resulted in significant decreases in Somatic Outgrowths in PLMs 
compared to control (Kruskal-Wallis p < 0.0001, H = 169), while knockdown of ins-38 resulted in a significant 
increase in Somatic Outgrowths in ALMs (Kruskal-Wallis p = 0.002, H = 68.71). Knockdown of ins-2, ins-9 and 
ins-16 resulted in decreases in Extended Somatic Outgrowths in ALMs, while knockdown of ins-3 resulted in an 
increase in Extended Somatic Outgrowths in ALMs (Kruskal-Wallis p < 0.0001, H = 189.8) and a decrease in 
Neurite Branches in PLMs (Kruskal-Wallis p < 0.0001, H = 121.5).
The second round of screening produced no significant changes in neuronal aberration occurrence across the 7 
selected genes, other than the ins-4 treatment, but did reveal changes in gentle touch response across multiple 
treatments (Table 1.2). The ins-4 knockdown treatment resulted in the decrease in Neurite Branches in ALMs 
(Kruskal-Wallis p = 0.004, H = 20.69), while touch response scores showed a significant increase in the anterior 
portion of animals (one-way ANOVA p = 0.031, F = 2.276) from the ins-9 treatment group and significant increase 
in the posterior portion of animals (one-way ANOVA p = 0.003, F = 3.274) from the ins-3, ins-4, ins-16, and ins-30 
treatment groups (Figure 1.6). Spearman correlation showed no relationship between any relative neuronal 
aberration occurrences and touch response in either anterior or posterior portions of animals from the seven 
rescreened treatment groups (Figure 1.7).
The third round of screening again resulted in several of the genes of interest showing significant changes in 
neuronal morphology, similar to the initial round (Table 1.3). The ins-1 treatment resulted in a significant increase 
in Somatic Outgrowths in ALMs (Kruskal-Wallis p = 0.021, H = 16.51), while the ins-3, ins-4, ins-9, and ins-30 
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treatment groups resulted in significant decreases in Extended Somatic Outgrowths in ALMs (Kruskal-Wallis p < 
0.0001, H = 33.95). Gentle touch response scores for the third round showed significant decreases in the anterior 
portion of animals (one-way ANOVA p = 0.045, F = 2.097) in the ins-9 and ins-16 treatment groups (Figure 1.8). 
Spearman correlation showed no relationship between any relative neuronal aberration occurrences and touch 
response in either anterior or posterior portions of animals from the seven rescreened treatment groups (Figure 1.9).
1.5 DISCUSSION:
1.5.1 Results interpretation
The results presented show that there are specific insulin ligands that play a role in maintaining the normal 
morphology of mechanosensory neurons. Interestingly, the results also suggest the possibility that insulin ligands 
modulate neuron morphology in a subfamily-dependent manner. The insulins that presented themselves as 
significant contributors in maintaining neuronal morphology during the first round of RNAi screening were ins-1, 
ins-2, ins-3, ins-4, ins-9, ins-16, ins-30, and ins-38 and the knockdown of these genes (except ins-38) in an 
individual manner produces morphological aberrations at a lower rate than control, meaning that their presence may 
be important for producing, or at least contributing to, what we define as aberrancies.
The results from the second round of RNAi screening were unexpected as experimental protocols were conducted 
without change. The lack of significant change in neuronal morphology and the parallel significant change in 
mechanosensory neuron function is somewhat counter intuitive to the first round results. These anomalous results 
are most likely explained by the variability in doses of RNAi treatments, an inherent design variable in the RNAi 
bacterial feeding method. A copy of the mec-4::gfp C. elegans strain was thawed and used for both the second and 
third RNAi rounds. If there were a failure to respond by the animals, these same results would be expected in the 
third round of RNAi, which was not the case. The only explanation we can propose is the possibility of a partial or 
incomplete incubation of RNAi E. coli clones on the second round treatment plate media prior to administration, 
leading to a decreased level of dsRNA for C. elegans uptake.
Results from the third round of RNAi screening were more consistent with the first round results in that significant 
changes were seen in the rescreen candidate treatments. The results, while similar, were slightly divergent from the 
first rounds'. ins-1 treatment produced a reversal of aberration occurrence with an increase in Somatic Outgrowths. 
ins-2 and ins-16 produced no significant change in morphology. The remaining ins-3, ins-4, ins-9, and ins-30 
treatment groups produced decreases in Extended Somatic Outgrowths, while not the standard Somatic Outgrowths 
seen in the first round, they were a type of Somatic Outgrowth and their occurrence was reduced along the lines of 
the first round, if we look at Somatic Outgrowths as a whole (Figure 1.10). Nevertheless, six of the seven rescreen 
candidates produced significant morphological changes again.
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When investigating the results for any correlations, it first appears that there was a relationship between the presence 
of aberrations and the improvement of mechanosensory neuron function. During the second round of RNAi 
screening, morphological aberration occurrence increased (though statistically insignificant) in relation to the first 
round with a corresponding increase in touch response score, while during the third round of RNAi there was a 
significant decrease in morphological aberrations and a corresponding decrease in some touch response scores. 
Upon Spearman correlation analysis between morphological aberration occurrence and respective touch response 
score, there was no relationship between the frequency of neuronal aberrations and touch response score. This lack 
of a relationship between “form and function” of mechanosensory neurons actually supports the uncoupled nature of 
neuronal morphology and function by DAF-2/DAF-16 modulation from previous research6-8.
Using these data from the RNAi screen, we searched for overlapping shifts in neuronal aberrations and gentle touch 
response over treatment rounds. We searched for overlap by consolidating anterior and posterior regions of animals 
for each neuronal aberration type and overlaid these results from each RNAi round using a Venn diagram. This 
visualization of RNAi response helps consolidate the separate responses and highlight any re-screen candidate ILPs 
as potential modulators of neuronal morphology. There was significant overlap when investigating all outgrowth 
types over the three RNAi rounds pointing to mainly p sub-type ILPs (Figure 1.10). When investigating overlap of 
regular Somatic Outgrowths (Figure 1.11) or Extended Somatic Outgrowths (Figure 1.12), the overlap of neuronal 
aberration decreases but still points to p sub-type ILPs as producing repeat shifts on event occurrence. When 
repeating this process for all Neurite Branches there is no overlap, but the two treatments from separate RNAi 
rounds where there were shifts in this aberration type both targeted p sub-type ILPs (Figure 1.13). This process was 
repeated for gentle touch response scores taken from the second and third rounds of RNAi, keeping anterior (Figure 
1.14A) and posterior (Figure 1.14B) regions of animals separate. Overlap of gentle touch response scores indicated 
only the ins-9 treatment as having any overlap between the second and third RNAi rounds. This treatment group 
displayed shifts in opposite direction between the second and third RNAi rounds.
1.5.2 ILP subfamilies and complex expression nature
ins-1, ins-2, ins-3, ins-4 and ins-9 are part of the same subfamily of insulin ligands, the p subfamily17. ins-16 and 
ins-30 are part of the γ and α subfamilies, respectively17. The y subfamily is characterized by the canonical disulfide 
bonds found in mammalian and most all other insulin ligands, and the a subfamily by nonpolar substitutions at the 
6/11 disulfide bond positions on the A peptide21. The p subfamily on the other hand is characterized by the three 
canonical di-sulfide bonds found in mammalian and most other insulin ligands, as well as additional di-sulfide bonds 
at position 21 of the A peptide and position 22, 23 or 24 of the B peptide17. This p subfamily contains C. elegans 
ins-1 through ins-10, with ins-1 thought to be the closest in structure to mammalian insulin peptide based on 
computer modelling19. Notable sequence alterations within the p subfamily of C. elegans ILPs are in the functional 
A and B peptides, with ins-1 having a 20 amino acid long C peptide that is cleaved contributing to its closest 
similarity to mammalian insulin, and ins-10 containing a cysteine substitution at position 15 of the B peptide thought 
to produce an additional disulfide bond17. Outside of these notable variations, the p subfamily remains largely 
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similar and homologous across the functional A and B peptides, with trivial residue variation most likely having no 
effect or leading to minor fluctuation in structure and binding affinity at the DAF-2 receptor40.
The grouping and specificity of the observed results is not entirely unexpected. The p subfamily of ILPs contains 
those that are closest to mammalian insulin, a major metabolic and growth regulator. Under normal laboratory 
conditions, as seen in this study, this subfamily may contain the standard ILPs utilized for normal adult growth and 
metabolism in mechanosensory neurons. Ashlyn Ritter discusses a “block design” for spatiotemporal ILP expression 
that could very well explain the observed pattern grouping of significant ILPs seen here as well as the reason C. 
elegans have 40 ILPs as opposed to the 10 seen in humans21. This concept operates on the idea that each C. elegans 
tissue type taps into specific groups and combinations of ILPs under different environmental conditions and, 
importantly, developmental stages. Environmental cues would allow differential access to ILPs that have a tailored 
use or combination with a suite of genes, possibly juxtaposed genomically, for said environmental conditions. 
Indeed many ILPs are in fact grouped in clusters according to their subfamily delineations across C. elegans 
chromosomes17. Different environmental and cellular conditions would call upon different lists of ILPs and 
associated gene expression to meet metabolic requirements and necessary changes. Since C. elegans is a very robust 
and hardy organism subject to extreme environmental and metabolic shifts, the expanded ILP family observed in 
their genome could be seen as a mechanism for fine tuning tissue growth and metabolism under various 
environmental conditions. This also appears to be the case for developmental stages wherein specific ILP expression 
is required to alter, progress, or halt development. Such is the case in dauer formation, an arrested development 
occurring during the larval 3 stage. Specific ILPs have been shown to enhance dauer entry or be upregulated during 
the dauer phase to maintain this specific life stage, while other ILPs have been shown to mitigate entry into 
dauer17,20,22,41,42. This life stage-specific expression is also seen throughout animal development wherein certain ILPs 
have variable expression based on specific time points in life throughout multiple tissue types21,22. This research into 
variable ILP expression provides a broad understanding of spatiotemporal IIS but specific quantitative data on whole 
worm ILP expression over time relative to other ILPs in age matched animals, or tissue specific ILP expression over 
time relative to other ILPs, has not been acquired. This spatiotemporal variability in ILP expression lends credence 
to the complex and specific expression dynamics of the greater C. elegans insulin signaling mechanism and to the 
possibility that what has been observed in this study is the knockdown influence of individual ILPs on only a single, 
conditional expression pattern for healthy aging animals in one tissue type, the mechanosensory neurons.
Complementing the spatiotemporal expression of ILPs, is the fact that these ligands can bind as either agonists or 
antagonists at the DAF-2 receptor, to either activate or inactivate signaling, respectively43. By modulating the 
relative concentrations of ILPs, the resulting competitive binding equilibrium at the DAF-2 receptor acts to regulate 
the frequency, interval, and duration of signaling. If cellular conditions result in high expression of antagonist 
relative to agonist expression, then DAF-2 signaling frequency is reduced and vice versa. Additionally, an ILP with 
a relatively high binding affinity will out-compete other ILPs at the receptor site and produce its 
agonistic/antagonistic effects relative to the other ILPs it is outcompeting. In fact, there is evidence that agonist ILPs 
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outcompete antagonist ILPs for access to the IR binding sites42. While the relative binding affinities of ILPs is 
largely unknown, specific amino acid substitutions at sites along ILP functional domains and even those nonbinding 
domains that influence ILP dimerization and tertiary structure, can impact receptor affinity and dissociation rate40. 
This behavior may help explain the unexpected results from the second round of RNAi screening, assuming the 
proposed explanation of incomplete treatment bacteria incubation and low RNAi doses are correct. This proposed 
explanation would be supported if the rescreen candidate genes act as agonists to the IR. Under proper dosage, 
RNAi would knockdown agonist ILPs. This would reduce IIS pathway signaling directly by removing the stimulus, 
and indirectly by removing competition from antagonist ILPs that reduce IIS. Under these conditions IIS would 
decrease overall, leading to a decrease in neuronal morphology aberrations. If low doses of RNAi were 
administered, then a failure to knockdown or incomplete knockdown of the candidate genes would result in 
continued expression of those agonist ILPs. This continued expression of agonist ILPs would activate/increase IIS 
pathway signaling directly through IR binding, and indirectly by outcompeting antagonist ILPs. Under these “failure 
to knockdown” conditions, IIS continues, resulting in a relative increase in neuronal aberration occurrence back to 
normal control wildtype levels. This may be a plausible explanation as modulating the IIS pathway for an overall 
increase in signaling is known to induce neuronal morphology aberrations6-8. Additionally, agonist ILPs 
outcompeting antagonist ILPs could help explain the overall decrease and the relative lack of increase in neuronal 
aberration seen in this study. If agonist ILPs outcompete antagonist ILPs42, then RNAi knockdown of antagonists 
should have little influence on the overall rate of IIS. While agonist ILPs establish binding dominance, reducing 
expression of the lower affinity antagonist ILPs will have little change on the established agonist ILP binding 
dominance. If knockdown of a high affinity, or highly expressed antagonist ILP were to occur, activated IIS may 
increase without restriction leading to an increase in neuronal aberration. This is most likely to have been the case 
with the ins-1 treatment group in RNAi round 3 where there was an increase in somatic outgrowth, INS-1 being a 
known antagonist ILP17,42.
The relative binding affinities of ILPs and their immediate binding roles as either agonists or antagonists is still 
largely unknown and in fact agonist or antagonist activity is not entirely conserved across ILP subfamilies with both 
activities seen in a given subfamily15,17,43,44. Several, but unfortunately not all, of the agonistic/antagonistic roles of 
C. elegans β sub-family ILPs are known15,17,18,37,41,42,45-48. The β sub-family comprises ins-1 through ins-10, and daf- 
28. Not all of the known agonist ILPs are in the p sub-family, although based on the results of this study, those 
agonists pertaining to neuronal morphology are. Ins-1 has shown both agonist and antagonist behavior. INS-1 acts as 
an agonist during salt chemo-tactic learning49. As an antagonist, INS-1 as well as its human homolog human insulin, 
act antagonistically on intestinal DAF-2 receptor to enhance dauer formation17, and INS-1 is secreted from neurons 
to suppress DAF-2 activity in thermos-tactic learning50. INS-2, INS-3, INS-4, INS-6 and DAF-28 are known to act 
from neurons as agonists on intestine to prevent dauer formation42. INS-4 and INS-6 again act as agonists in sensory 
and motor neurons to regulate neuromuscular junction synapse development15. INS-7 has exhibited both agonist and 
antagonist characteristics depending on the experimental endpoint. As an agonist influencing lifespan and dauer 
formation41, and as an antagonist in RIA head neurons that blocks DAF-2 activity to repress olfactory learning44.
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INS-9 only appears in ASI and ASJ amphid neurons, and acts as an agonist to regulate dauer formation51. The 
function and binding roles of INS-5, INS-8, and INS-10 are still unknown, but INS-5 and INS-10 are thought to 
have agonist behavior based on their influence on dauer formation20,45. Outside of the p sub-family, binding roles of 
many ILPs are known but remain unclear. For example; INS-12, INS-17, INS-18, and INS-23 act antagonistically to 
promote dauer formation and/or longevity17,42,46,48,52,53, yet INS-12 has displayed both agonist or antagonist behavior 
depending on dauer exit or entry, respectively20,42, as an experimental endpoint. INS-33 has displayed both agonist 
and antagonist behavior48 as well, as an agonist in germline proliferation54, and as an antagonist in regulating dauer 
formation55. INS-35 has displayed contradictory agonist20 and antagonist55 behavior when it comes to dauer 
formation. The ILPs with known agonist and/or antagonist roles are summarized in Table 1.4 including the RNAi 
re-screen candidates with their respective changes in neuronal morphology compared to any known 
agonist/antagonist role.
Previously published ILP activity, regarding agonist and/or antagonist roles, largely agrees with results from this 
study. As stated previously, five of the seven re-screen candidate ILPs fall within the p sub-family. When INS-1 was 
knocked down we observed an initial decrease in neuronal aberration consistent with agonist behavior, but upon re­
screen we observed an increase in aberration consistent with knocking down a significant antagonist, which INS-1 is 
known to be17,42(Table 1.4). This supports the dual binding behavior that other researchers have described17,50. 
When INS-2, INS-3, and INS-4 were knocked down we observed a decrease in neuronal aberration events, as would 
be expected when knocking down agonist ILPs. INS-2 through INS-4 are also known to be agonists that prevent 
dauer formation42. INS-9 is thought to be an agonist that regulates dauer control by secretion from specific 
neurons51, and RNAi data from this study reports results consistent with agonist activity, a decrease in neuronal 
aberration when knocked down. We therefore propose that INS-9 is an agonist ILP. INS-16 and INS-30 are y and a 
sub-types, respectively. The function and agonistic role of these ILPs is still unknown but they may be possible 
agonist ILPs as well, seeing as they produced decreases in neuronal aberrations when knocked down. While several 
y ILPs have been shown to act as antagonists, binding roles are not conserved across sub-families, like as seen with 
the dual binding roles of INS-1 and INS-7 in the p sub-family.
Complicating the roles of ILPs further is the fact that they can initiate self-feedback loops and can mediate ILP-to- 
ILP interactions with one another. An example of the first scenario is that INS-18 is the sole ILP expressed in 
Hermaphrodite Specific Neurons (HSNs) and acts antagonistically on DAF-2 to upregulate DAF-16 nuclear 
translocation43. DAF-16, once translocated, activates ins-18 transcription, creating an ins-18 positive antagonistic 
feedback loop in HSNs. Another such case is INS-7 acting as an agonist that contributes to normal development and 
prevention of dauer formation. Upon agonist binding at DAF-2, DAF-16 translocation which normally 
downregulates INS-7 production is prevented, thus leading to an increase in INS-7 production and an ins-7 positive 
agonist feedback loop41. An example of ILP-to-ILP interaction is INS-6 functioning to repress INS-7 in URX 
neurons15 or that loss of INS-7 can upregulate INS-8 approximately 15 fold in endogenous whole animal 
expression21.
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To further investigate the agonist and antagonist roles of individual ILPs we propose a study with a more direct IIS 
pathway response than what has been conducted in previous work. We propose a study similar to what we have 
done here, a reverse genetic screen of ILPs. The natural starting point being to knockdown the ILPs whose 
agonist/antagonist roles are thought to be known. This proposed screen would use a C. elegans daf-16::gfp reporter 
mutant with ubiquitous SID-1 channels. RNAi would then be used to knockdown ILPs and the nuclear translocation 
activity of daf-16::gfp reporter would be discerned. This would allow us to build a more accurate representation of 
ILP's binding roles on the IR, as daf-16::gfp translocation is a more immediate IIS pathway response than the 
previously used dauer diapause. Knockdown of agonist ILPs would lead to an increase in daf-16::gfp translocation, 
while a knockdown of antagonists should result in a decrease of daf-16::gfp translocation. In treatments where daf- 
16::gfp is already low, a heat-shock treatment to raise daf-16::gfp expression could be used in conjunction with 
RNAi knockdown to determine a relative decrease in daf-16::gfp expression occurs. This study also has tissue 
specific implications as daf-16::gfp translocation could be determined in different tissue regions, helping to clarify 
some of the self-contradicting binding behavior of certain ILPs like INS-741,44.
Additionally, we propose studies quantifying ILP mRNA expression levels similar to that conducted by Ryan 
Baugh22. In particular, by using age-synchronous, unmixed populations, to determine ILP mRNA expression levels 
at multiple time points, reaching past the 60 h of total life as previously reported. Knowing these relative expression 
levels of ILPs over time would help determine long term versus episodic ILP expression and which ILPs to focus on 
during the later stages of life when cognitive decline and neurodegeneration become prevalent.
1.5.3 Concluding remarks
It is clear that IIS signaling is still a very complex and conditionally specific molecular topic and that there is still 
much more to explore in regards to individual ILP's roles and relationships to one another in each tissue type of 
expression. With this in mind, perhaps what this study has shown is a glimpse into insulin signaling and its 
morphological outcome on regular neuronal sprouting/regeneration in healthy aged neurons. This knowledge can be 
used as a basis for identifying specific ILPs or their respective subfamilies, the p subfamily in this case, that play 
foundational roles in regular neuronal morphology and neurodegeneration. Knowing how normal, healthy neurons 
utilize IIS to maintain health and function will be important in the future of human health as genetic factors may 
play roles in neurodegeneration, such as family history of AD being correlated with higher levels of circulating IGF- 
1 in mice56, and impaired IIS and expression of IIS pathway constituents being implicated as a mechanism in human 
AD57, one of the major forms of neurodegeneration seen in the growing geriatric population.
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1.9 FIGURES AND TABLES
Figure 1.1. Insulin and Insulin-like Signaling (IIS) 
pathway. Graphic from Scerbak et al, 2014 (Figure 
l)12. Graphical depiction of the IIS pathway and ma­
jor molecules involved in signal transduction, human 
homologues in parantheses. ILP ligands bind to DAF- 
2 receptor, this induces a phosphorylation sequence 
that results in the targeted inhibition of DAF-16 nucle­
ar translocation. DAF-16 is a prolongevity transcrip­
tion factor. Under normal operation agonist binding at 
DAF-2 inhibits DAF-16 translocation and antagonist 
binding at DAF-2 dis-inhibits DAF-16 translocation.
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Figure 1.2. Morphological aberration categories. Representative im­
ages of a healthy neuron and its morphology (A) compared to those 
with morphological aberrancy; in the form of Somatic Outgrowths 
(B), Extended Somatic Outgrowths (C) and Neurite Branches (D).
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Figure 1.3. Gentle touch response temperature and L4440 vector validation. Anterior (A) and posterior (B) touch response 
scores of L4440 treatment vector versus the standard OP50-1 E. coli food source at both 20°C and 25°C. L4440 treatment is 
an E. coli clone containing an empty L4440 plasmid that is used in clones hosting RNAi knockdown treatment. Significant de­
crease in anterior touch response in both OP50-1 and L4440 treatments when conducted at 25°C compared to 20°C, indicating a 
decrease in functional health. Analysis reported L4440 as a source of significant differencein in posterior touch response when 
compared to OP50-1 at both 20°C or 25°C. n=30 animals for each treatment group, (*=p < 0.05), (*=p< 0.01 ),(*** =p<0.001).
32
Figure 1.4. Mean total aberrations temperature and L4440 vector validation. Mean anterior (A) and posterior 
(B) total aberrations per animal when fed L4440 treatment vector versus the standard OP50-1 E. coli food source at 
both 20°C and 25°C. L4440 treatment is an E. coli clone containing an empty L4440 plasmid that is used in clones 
hosting RNAi knockdown treatment. No significant change in mean anterior total aberrations from either increased 
temperature or from L4440 vector. L4440 was not a significant source of variation in mean posterior total aberra­
tions at either 20°C or 25°C. A higher temperature was reported to be a significant source of variation in mean pos­
terior total aberrations within OP50-1 and L4440 groups. n=30 animals for each treatment group, (** =p < 0.01).
33
Figure 1.5. RNAi influences target mechanosensory neurons. Anterior (A) and posterior (B) touch response of 
mec- 7 knockdown treatment versus L4440 control, mec- 7 is a required gene for proper mechanosensation. Statisti­
cally significant decreases in both anterior and posterior touch response of mec- 7 treatment group, showing the arrival 
and influence of the RNAi treatment on the neurons of interest. n=30 animal for each treatment group (** =p < 0.01).
34
Figure 1.6. Second round RNAi screen mechanosensory function. Mean anterior (A) and poste­
rior (B) gentle touch response of treatment groups for seven ILPs of interest compared to L4440 con­
trol. ins-9 treatment saw a statistically significant increase in anterior touch response, ins-3, ins-4, ins- 
16, and ins-30 treatment groups saw statistically significant increases in posterior touch response. 
Approximately n=30 animals for each treatment group, * = p<0.05, ** = p<0.01 and *** = p<0.001.
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Figure 1.7. Second round RNAi screen neuronal aberration and touch response correlation. Spearman correla­
tion analysis of mean morphological aberration occurrence versus gentle touch response score of each treatment group. 
Mean anterior (A) and posterior (B) touch response of L4440 and seven selected treatment groups versus their respec­
tive somatic outgrowths occurrence. Mean anterior (C) and posterior (D) touch response scores of control and seven select­
ed treatment groups versus their respective Extended Somatic Outgrowths occurrence. Mean anterior (E) and posterior (F) 
touch response scores of L4440 and seven selected treatment groups versus their respective Axonal Branches occurrence, 
rs-values indicated no correlation between touch response score and aberration occurrence in anterior or posterior 
mechanosensory neurons.
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Figure 1.8. Third round RNAi screen mechanosensory function. Mean anterior (A) and posterior (B) gentle 
touch response of treatment groups for seven ILPs of interest compared to L4440 control. ins-9 and ins-16 treat­
ments saw statistically significant increases in anterior touch response. No statistically significant difference in pos­
terior touch response for any treatment group. Approximately n=30 animals for each treatment group, * =p<0.05.
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Figure 1.9. Third round RNAi screen neuronal aberration and touch response correlation. Spearman correlation anal­
ysis of mean morphological aberration occurrence versus gentle touch response score of each treatment group. Mean ante­
rior (A) and posterior (B) touch response of L4440 and seven selected treatment groups versus their respective Somatic 
Outgrowths occurrence. Mean anterior (C) and posterior (D) touch response scores of control and seven selected treatment 
groups versus their respective Extended Somatic Outgrowths occurrence. Mean anterior (E) and posterior (F) touch response 
scores of L4440 and seven selected treatment groups versus their respective Neurite Branches occurrence. rs-values indicat­
ed no correlation between touch response score and aberration occurrence in anterior or posterior mechanosensory neurons.
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Figure 1.10. ILP knockdown treatments displaying significant 
changes in all somatic outgrowth types. Venn diagram illustrat­
ing overlap of RNAi knockdown treatments that produced signifi­
cant changes in any outgrowth type. Somatic Outgrowth and Ex- 
tended Somatic Outgrowth have been merged anterior and posterior 
regions have been merged as well. ILP sub-family is in parenthe­
ses, arrows sequentially depict relative shift in aberration occurrence.
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Figure 1.11. ILP knockdown treatments displaying significant 
changes in somatic outgrowth. Venn diagram illustrating overlap of RNAi 
knockdown treatments that produced significant changes in somatic out­
growth. Anterior and posterior have been merged. ILP sub-family is in pa 
rentheses, arrows sequentially depict relative shift inaberration occurrence.
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Figure 1.12. ILP knockdown treatments displaying significant 
changes in extended somatic outgrowth. Venn diagram il­
lustrating overlap of RNAi knockdown treatments that pro­
duced significant changes in extended somatic outgrowth. 
Anterior and posterior have been merged. ILP sub-family is in paren­
theses, arrows sequentially depict relative shift in aberration occurrence.
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Figure 1.13. ILP knockdown treatments displaying significant 
changes in all neurite branches. Venn diagram illustrating overlap of 
RNAiknockdown treatments that produced significant changes in all neurite 
branches. Anterior and posterior have been merged. ILP sub-family is inpa­
rentheses, arrows sequentially depict relative shift in aberration occurrence.
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Figure 1.14. ILP knockdown treatments displaying significant changes in gentle touch response. Venn diagram 
illustrating overlap ofRNAi knockdown treatments that produced significant changes in anterior (A) and posterior (B) 
gentletouchresponse. ILPsub-family is in parentheses, arrows sequentially depict relative shift in aberration occurrence.
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Table 1.1. RNAi screen of 39 C. elegans ILPs. Mean event occurrence of morphology aberrations per ALM or PLM. All 39 available C. elegans ILPs 
targeted and compared to L4440 control, highlighted in light grey. Occurrences with p<0.1 are highlighted in dark grey. Arrows in treatment column 
denote the relative shift in aberration occurrence compared to L4440 control. Anterior and posterior categories are composed of 
both ALMs or PLMs from each animal, for approximately 60 ALMs and PLMs counted per treatment group. ψ ins-38 not se­
lected as a rescreen candidate in an initial data analysis that selected for genes with “significant” and “almost significant” shifts in 
more than one category/location, nonetheless ins-38 knockdown did show a statistically significant shift in aberration occurrence.
RNAi Treatment
Outgrowths Extended Outgrowths Branches
Anterior Posterior Anterior Posterior Anterior Posterior
L4440 0.836 0.241 0.400 0.056 0.400 0.259
ins-1 | 0.829 0.000 0.098 0.000 0.122 0.400
ins-2 ↓ 0.983 0.035 0.033 0.000 0.356 0.754
ins-3 1.050 0.068 ↓0.1 0.000 0.283 ↑1.034
ins-4 | 0.706 0.000 0.118 0.000 0.078 0.146
ins-5 1.071 0.093 0.196 0.000 0.446 0.426
ins-6 0.933 0.068 0.250 0.000 0.117 0.203
ins-7 1.133 0.133 0.300 0.000 0.767 0.417
ins-8 0.833 0.043 0.125 0.000 0.104 0.196
ins-9 | 0.966 0.035 0.017 0.000 0.121 0.140
ins-10 0.915 0.104 0.390 0.000 0.356 0.229
ins-11 1.036 0.204 0.327 0.000 0.346 0.315
ins-12 1.085 0.220 0.153 0.051 0.458 0.441
ins-13 1.175 0.286 0.351 0.020 0.368 0.490
ins-14 1.054 0.083 0.268 0.021 0.286 0.042
ins-15 1.300 0.200 0.283 0.017 0.250 0.333
ins-16 ↓ 1.018 0.130 0.091 0.000 0.164 0.093
ins-17 0.860 0.105 0.526 0.000 0.211 0.386
ins-18 1.000 0.136 0.250 0.034 0.083 0.136
ins-19 0.818 0.093 0.227 0.000 0.205 0.047
ins-20 0.900 0.067 0.150 0.000 0.283 0.100
ins-21 1.200 0.186 0.267 0.017 0.500 0.610
ins-22 0.950 0.203 0.383 0.000 0.583 0.373
ins-23 1.000 0.121 0.317 0.052 0.100 0.241
ins-24 1.229 0.292 0.417 0.021 0.229 0.596
ins-25 1.172 0.351 0.276 0.000 0.466 0.281
ins-26 1.278 0.333 0.352 0.037 0.500 0.315
ins-27 1.300 0.316 0.300 0.035 0.167 0.404
ins-28 1.033 0.339 0.517 0.034 0.267 0.153
ins-29 1.043 0.250 0.340 0.045 0.404 0.546
ins-30 | 0.880 0.000 0.180 0.000 0.260 0.160
ins-31 0.897 0.362 0.603 0.052 0.552 0.362
ins-32 1.183 0.383 0.517 0.017 0.683 0.233
ins-33 1.149 0.208 0.277 0.021 0.298 0.271
ins-34 1.017 0.123 0.203 0.018 0.203 0.175
ins-35 0.814 0.250 0.627 0.000 0.136 0.367
ins-36 1.179 0.214 0.339 0.054 0.411 0.214
ins-37 1.152 0.242 0.258 0.061 0.424 0.152
ins-38^ ↑ 1.294 0.182 0.162 0.000 0.191 0.152
daf-28 0.932 0.184 0.271 0.000 0.170 0.190
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Table 1.2. Second round RNAi screen of C. elegans ILPs of interest. Mean event oc­
currence of morphology aberrations per ALM or PLM in treatment groups for ILPs of 
interest. Seven C. elegans ILPs targeted and compared to L4440 control, control high­
lighted in light grey. p-values of <0.1 are highlighted in dark grey. Arrows in treat­
ment column denote the relative shift in aberration occurrence compared to L4440 
control. Anterior and Posterior categories were comprised of both ALMs or PLMs 
from each animal, for approximately 60 ALMs and PLMs counted per treatment.
RNAi treatment
Outgrowths Extended Outgrowths Branches
Anterior Posterior Anterior Posterior Anterior Posterior
L4440 0.744 0.000 0.180 0.000 0.333 0.000
ins-1 0.750 0.000 0.125 0.000 0.150 0.103
ins-2 0.872 0.000 0.231 0.000 0.077 0.056
ins-3 1.000 0.051 0.282 0.026 0.333 0.103
ins-4 ↓ 0.925 0.025 0.175 0.000 0.000 0.025
ins-9 0.825 0.077 0.250 0.000 0.250 0.000
ins-16 0.800 0.000 0.275 0.000 0.050 0.025
ins-30 0.775 0.050 0.150 0.000 0.125 0.000
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RNAi Treatment
Outgrowths Extended Outgrowths Branches
Anterior Posterior Anterior Posterior Anterior Posterior
L4440 0.750 0.083 0.333 0.000 0.100 0.050
ins-1 ↑ 1.183 0.100 0.200 0.000 0.100 0.033
ins-2 0.750 0.067 0.433 0.000 0.100 0.000
ins-3 | 1.067 0.150 0.133 0.000 0.150 0.017
ins-4 | 0.967 0.067 0.100 0.000 0.167 0.017
ins-9 | 0.933 0.083 0.117 0.000 0.017 0.000
ins-16 0.850 0.033 0.167 0.000 0.117 0.017
ins-30 | 0.800 0.133 0.100 0.000 0.050 0.000
Table 1.3. Third round RNAi screen of C. elegans ILPs of interest. Mean event occurrence of 
morphology aberrationsperALMorPLMintreatmentgroupsfor ILPs of interest. Seven C.elegans 
ILPs targeted and compared to L4440 control, control highlighted in light grey.p-values of <0.1 
are highlighted in dark grey. Arrows in treatment column denote the relative shift in aberration 
occurrence compared to L4440 control. Anterior and Posterior categories were comprised of both 
ALMs or PLMs from each animal, for approximately 60 ALMs and PLMs counted per treatment.
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Table 1.4. Known agonist/antagonist ILP activity and RNAi re-screen candidate morphology changes. List of 
ILPs with known agonist and/or antagonist roles at the DAF-2 IR in C. elegans. RNAi re-screen candidates (high­
lighted grey) are included with their respective changes in neuronal aberrations listed for cross-referencing with any 
previously known agonist/antagonist activity. Changes in neuronal morphology are represented by the RNAi round 
number with an arrow showing the relative shift in aberration occurrence when the target ILP was knocked down. In 
RNAi treatment aberration categories where there is no significant change, “N.S” is used. “N/A” represents informa­
tion that is not available. References for known agonist and antagonist behavior are included as superscript numbers.
ILP
gene
ILP 
sub-family
Known ILP
Agon./Antag. 
activity
Neuronal aberration changes observed by RNAi round
RNAi result as agonist/ 
antagonist consistent 
with published literature?
Outgrowths
Extended Out­
growths
Branches
Anterior Posterior Anterior Posterior Anterior Posterior
Hu Ins Y Antagonist17 ... ... ... — ... ... N/A
ins-1 P Ag49/Ant1742-50 3↑ 1↓ N.S. N.S. N.S. N.S. Y (Ant.Out.)17,42,49,50
ins-2 P Agonist42 N.S. N.S. 1↓ N.S. N.S. N.S. Y«
ins-3 P Agonist42 N.S. N.S. 1↓3↓ N.S. N.S. 1↑ Y (Ext.Out.)42
ins-4 P Agonist15,42 N.S. 1↓ 3↓ N.S. 2↓ N.S. Y 15,42
ins-5 P Agonist2045 ... ... ... ... ... ... N/A
ins-6 P Agonist15,42,47,48 ... ... ... ... ... N/A
ins-7 P Agon4’/Antag44 ... ... ... ... ... ... N/A
ins-9 P Agonist51 N.S. N.S. 1↓3↓ N.S. N.S. N.S. Y51
ins-10 P Agonist20-45 — — — ... ... ... N/A
ins-11 Y Ag20,45 /Ant58,45 ... ... ... ... ... ... N/A
ins-12 Y Antagonist49 ... ... ... ... ... N/A
ins-14 Y Agonist20-45 ... ... ... ... ... ... N/A
ins-16 Y N/A N.S. N.S. 1↓ N.S. N.S. N.S. N/A
ins-17 Y Antagonist46 — ... ... ... ... ... N/A
ins-18 Y Antag17,42,46 ... ... ... ... ... ... N/A
ins-20 a Antag20,45 — ... ... ... ___ ... N/A
ins-21 CL Agonist2045 ... ... ... ... ... ... N/A
ins-22 a Agonist20,45 ... ... ... — — ... N/A
ins-23 CL Antagonist53 ... ... ... ... ... ... N/A
ins-26 α Agonist20,45 ... ... ... ... ... ... N/A
ins-27 α Agonist2045 ... ... ... ... ... ... N A
ins-30 a N/A N.S. I↓ 3↓ N.S. N.S. N.S. N/A
ins-33 a Agon54/Antag55 ... ... ... ... ... ... N/A
ins-35 a Ag20,45/Ant55 ... ... ... ... ... ... N/A
daf-28 p Agonist18,20,42 ... ... ... ... ... ... N/A
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RNAi 
Clone
Sequence Read
L4440 GGCNCTAGNCNTNNANACTCGNNCGAAGGGNAGTCGCTCTACCTTCTGCCCANNNTACTTCGTGATATNNNT-  
CATTTCCTCCCATTTCACNGCACCAGTCAGCAATNNCTGCTCCTTTCTGGATAAATTTTGCNTCNCTTTCATTTCCNNAANNNNCCTCT- 
CATAACNATCAGAAAGNAGNCNGTAACAATTTNNNAGCTCTCGACCTTNANTTTCCGGCNNANAANCGTAAAGTTTTCCGATTTCCNNGN- 
CATTTNANACGCGATNCNNGNGGTCAACCTACGGCGTGAATCTAGAATTGACNGAAGGANATATTTTNACGANNNCAAAAAACATA- 
AANANNNAATCAANTNNACAAAGTTNNNTNCGTCCGCCACCACAGANNNGC'TCGACTTCGTCTTTCAGATGNNATNNGCGNNACTC- 
GCTCNNNAGAGTGTCGTAATACTNNAGCAGCCGAGATCAAGTTNNTCAANNAGANNNAANNTGCNNNNNCNNNNNTNNNNNNNGN- 
TACCGATTCCTATCAANNNGAGGGTGCCGGNNNNTTTTNATNGGANNCNNNTTNATTACGNNCGACATAAANNGGGAAC'GTA- 
ATGCCTAAATNANNNAGAANNGCGATAAACNGNNNNNANNTNCGNNNNCTGNNNTACNNTCCAATNNATGAAGNNNNTNTN- 
NATNNNNACTNNNNNNCAACCACGTTGATGAGTNNNCAAT
ins-1 NCCNANCTNTNTAGGGCGATTGGGTACCATTATCGTCCTGATTGCAGCAGAATGTTTTGAGATATGCAAATGAACATCGCTTCTCACAA- 
CATTCTGTCGCAATTCCGCCTCGCTTTTGTTGGTGGTGAATGTGAAAAAGATCGCGAGTTGTTGGTGCATAGGATTGGTCGGCGGAAC- 
GTTTGAAAGCGGTTAATCCAGTGCACAGCTGATTCCGGCATACTGCTAAAAGGGTTGTTGTGAGACGTGATCCACATAGTCGAATCGATGC-  
GTCTGAAGGCGTCGGCGACGAGAGGAGAAGGATCGCGAGAAAGCCAAAGAAGAACGAGGGTCTGTAAACTTGACGAAACCAGTACAT- 
GCGGCCGCCACCGCGGTGGAGCTCGAATTCATCGATGATATCAGATCTGCCGGTCTCCCTATAGTGAGTCGTATTAATTTCGATAAGCCAG- 
GTTGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATC- 
CACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTG- 
GCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAA- 
GATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCG 
GGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCAC- 
GAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAG- 
CAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAA- 
GAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAAAANCCACCGCTG- 
GTAACGGTGGTTTTTTTGTTTGCAAGCAGCNGATTACCNGCAGAAAAAANGGATCTCAGAANNNTCCTTTGATCTTTNCTACGGGGTCT- 
GANNGNNNNTGGAANNNAANCTCCNGTTAAGGGATTTGGNCCNGAGATTNNCNAAANGGNNNTTCCNNAANTCCTTTNAATTAAAANG- 
GNGNTTNCAACCACCCNAANNANNTNNNAANNCATTGNNTNNNNCGTTNNNNCTGCTTAATGCGNGGNN
ins-2 NNNNNNNNNNNNNNNNNNNGANNNNNNNNNGGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNG- 
TATTAAGAAAACTAACATTTTGAAAAGTTAATGATAGTACGATANGTCCATAACTATTTTCTAAATGAATTCGGGCAGCAGACTCTGAT- 
GATATCTTGAACGTCACATNGTTTTATGCAGCAAATATGCGAAAGGTCTTCTGATGAATCTGAAATGTATCATATGTTTAAAGGGTGAAC- 
GTTTGAAACAGTATGAAAAACAATAGTTGGACTTTTTGACGTCCTGAAAATTCTTATAAATGTATGCCTGCCTTCAATGCGATCAACGCAT- 
GCAATGCGTAGACATGTACGGCGCGTTTTGTTGAAGTATTAATTTTCAGAAACAAAAAATCTTTCCAGAATAAATTGACAATTTCAAAATT- 
TAATTTTTAATAGTAATCATTTTATTAACTCAAAATTTTCTAGAATTGAATGAATTTCCATTAAAGTTTTACGTTCAAAAATAATTTTAATACT- 
TAAAAAAAAAGTCGTACCTGTATCACATTCTCCACATGTTGCAAGCATGAATAAAATAAGACGTCTTCCGCATAGACGTTTCTGGACTCTT- 
GAGGCACGGTTTGGAGTTGGAGTTGACTCAACTGGTATGATATCAAGTTGATTGATGATCAAATGTTCATTTCTGTGTTCTATTCCTTTTC- 
CGAAAACTTCATAAGTGGCAGTGACAGTTGTGAAGAGGAGACAGAAGATTATAGCGTTCATGGTAGATTTTAGAATGGAAAGGAAAGAA- 
CATCTACGGCACTTTTTGTTTTTATACCGTTTTTAAACGTAGGGAGGGCGTGGCAGGAGGCATCGTTTTTGGGATTAGGTAGAAATGGGAC
GACAATCAGATCTGCCGGTCTCCCTATAGTGAGTCGTATTAATTTCGATAAGCCAGGTTGCTTCCTCGCTCACTGACTCGCTGCGCTCG- 
GTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGNATAACGCAGGAANGACCT-  
GTGAGCAAANGCCAGCANAAGGCNNGAACCGTANAAGGCCGCGTTGCTGGCGTTTTTCCTAGGCTCCGCCCCCTGACAGACATCA- 
CAAANTNC'ANNCTCAATTCGAAGTGGNCAAACCCCNNGGANNNAANAANCCNGNGNTTTCCCNTGGAAATCCCCCCNGNGNCTNC- 
CGTTNCNNACCGGCCNTNNNACGAACACNCNNCCNNCTTCCNTTCCGGAAGNNNGGTTTTNCNANNCNCTANNNCCNGNNT- 
CAACNNNNGNAANNNGNCNNNNNNNCCNGGNNCNNNN
ins-3 NNNCAANCNTNCCTANGGNCGANTGGNNNCTCTTGANGGNCAGCACTTNGTAGTTATNTCTTCCATTGTGCACATTTTTTCACAGCATTCT- 
GTAGCGATGTTCTCATTCGTTGATGAACATTCTCCTCCACACATTACCATCACCATTTTCAGAACTTTTGTACCACAAATCTTCACTTT- 
GTCTCCTCTTCTTGATCTGGCCATCAGGGAGTGAATGTTATGGAATCCAATTTCCGAATCATCATAATCGTGTTCCAATTCTTTCTCAAAATC- 
GAACATCCAGTTACGCATAAGACTTGCAGCTCCAAGTTGGAAAATAATGAAAAGTGCAAGAACAACGGAGAGTTTCATGCGGCCGC- 
CACCGCGGTGGAGCTCGAATTCATCGATGATATCAGATCTGCCGGTCTCCCTATAGTGAGTCGTATTAATTTCGATAAGCCAGGTTGCTTC- 
CTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAAT- 
C’AGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTC- 
CATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAG- 
GCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGC'CTTTCTCCCTTCGGGAAGC- 
GTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCC- 
GTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGC- 
CACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAA- 
CAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAACCACCGCTGG- 
TAGCGGTGGTTTTTTTGTTNGCAAGCANNNNATTACCNGCAAAAAAANGGATNTNNNNANANNCNTTTNATCTTTTTNANGGGNTN- 
NAAGCNNNNTGGAANCAAANNNNCCTTNAAGGNNTTGTGNNNGCAGATTATTACAANGATGTTNCCNNNAATTNNTTTTNANNN- 
NAAAANNANNTTTNAACANNCCNNNAACTAANNGNGNANNACNNNNNTNNN
ins-4 NNNNNNNNNNNNNNNNNNNGANNNNNNNNNGGNNNNNNNNNGNNNNNNNNNNNGNNNNGNNNNNNNNNNGNNNNNN 
NNNNNNNNNNANNNNNNNNNNNNAANNNNANNAANNACNNNAATTNCAAGCTCTTCAAAAAGATGGTTAATTTTCATA- 
ATTTTTCAGAAGTTTTTCAAAAGCTCCAAGAGAATGTTTTCATTCTTTACATATTTCCTTCTCTCCGCACTTCTTCTCTCCGCTTCAT-  
GTCGACAACCTTCCATGGACACCAGCAAAGCCGATCGTATTCTACGAGAGATCGAAATGGAAACAGAACTCGAAAATCAACTCTCCC- 
GAGCACGACGAGTCCCAGCTGGAGAGGTTCGTGCCTGTGGAAGACGACTTCTTC'TNCTTTGTCTGGTCAACCTGTGGAGAACCAT- 
GCACGCCACGTACGTTTAATGCTAAAAATTTTTTAAAAAACCTTAATCTGAATTTATTATTTTTCAGAAGAGGACATGGACATTGC 
CACAGTTTGCTGCACAACACAGTGCACTCCATCATATATAAAACAAGCTTGCTGCCCAGAAAAGTAAAAACAGTCGTCCAACAAGC- 
CATCTCCGTCGTCAAATAATTTTCAATAGAGTCTAGATTTTCTCCATTCACAAACTTTCCATTTTAATTTCCATGTGCAACCAATTCCTGCTCT- 
CAAAGTTCCAGGCTTCTCCTACAATCAATCTTCNAAAGATCTCTTTCATCCCGTTACAGTAACTTGTTTTCAAAATGATCTCACTATTTA 
TTTTT CTGCAATAAAACTTTTTGAATAAAN TTCCTTTCATAATACCCATGTTCAATGATAGAGTGAATAATGA........... (CONTINUED)...........
Supplementary Table 1.5. RNAi clone DNA sequencing.
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ins-4 ....(CONTINUED).... TTTTTATTATGAAACGGAGGGACGGTTGTCT TNTTTATCAANAAGGGAAACAACTTTAACTTTTAGATTTTTGATA- 
NAATTACCTCTTCTATGTACGAGCAAAGAACTTCTGATTTTCCGTTAATATTTTTCTAGATATCAAGAATTTTTTTATTGTTTCAATTTA- 
ATGAAAGCACTATGCATATACGTAGTCTTAATTTTATATGATGGAAATATTATAATTTGAAATATTAACTTTAAACCCAATTCTTTCAANTC- 
TAAAAANCAGTCATTATTTGGAATCCTTGTCGTTTTTGAATCAGATCTGCCGGTCTCCNNNNANNGAGTCGTATTAATTTCNNNANNC- 
CAGGTTGCTTCCTCNCTCACTGAACCCNNNGCGCNNNGGNCGTTCGGNNNGGNNNNANGGGNTNNNNNNTCCNTCCAANAGGNG- 
GTNNNNNGGNTTNNCCCCNGAANNCNGGGGGNNNAACCCCNGGNANAAAANCTTNTNNNNNNAAANGGNNNNNNAAAANGNNCCNG- 
GAANCCNNNA
ins-9 GGNCGNNNNCNNNANCNNNNTACCNTNAANNNCCGGGNNGGGNCGGNANNTNNNNNGGGNNANCCCNNAAATTTNTCTG- 
GTTTCCGNGGCCACNAAGNCCAATNGGNCCTNNNTNTCCCNNNNGNAATTNNNTCNAAACCGTAAAANNGGTTNNC- 
CANTNNTNNGGGGTTNTNNCCCCACCAAGGCCAACCAAGNCCTTNTANGNANGNNNGNAANNCCCNTTNGGTTTTCCCNGGT- 
NANCCCCTNAAAANNAAAATTANTTTTTTANTTCCCGNAATTTTTTTCGGAATTTTTTTNANNGAGGAAAACCAAANAACCGNAAT-  
TAACCTTTNANCCCCCCGNNGGTTTNCNACCAATCGGGGCCNCCCCGGTTTCGGCCAACCGGCCTCGGANTCANGCCNACCAATTC- 
CANGNTCGGTCAAGNNNGGTTTTTNTTCCTTTTCCCCACCAAGCCNGNGNTNANGAATTTTTTTTTTTNCCGAGGTTTTTCCCCAAGGGTT 
TTCTTTTCCTCCGNCCCCNGAATTTTTCCCATCGNGTCGNATCGNGTGGGGTCGGGGTTGNATTGNATCGAATTTACTCGACGNGNT- 
GNGNAGNGAATNTNTNCTTCGCNNTNCCATTGNAGNANCNAAATNCNANAATGGNANTTTNANAGAANTNCCATTTTTNCNGNTT- 
GTTTTNCCAGATNANCNTAGAGNANAAGGGTGGTGCNNCNATTTGNANAGTTCCAANTNGN ACAAGNANAAGAAACAAT- 
CAAAGNTTGNACGATTTCATGCGGNCCCNGCCACCGNCGNNGTGGAAGCTTCNGAATTCANTNCGATGATNANTCAGATTCTNGNCCG- 
GTCTNCCCNTATAGTGAGTCNGTATTAATTTT CGATAANGCCAGGTTTGCTCCTCNGTCATNGACTCGCTT GCGCTCGNGTCGTTTCG- 
GCTTGCGGCGAGCGNGTATCAGCTTCACTCAAAGGCGNGTAATACGGNTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGT- 
GAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCAT- 
CACAAAAATCGACGCTCAAGTCAGAAGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCNTCGT- 
GCGCTCTCCTGTTCCGACCTGCCGCTTACGGATACCTGTCCNCTTNCTCCNTTCGGAACGTGGCGCTTCTCATACTCNCCTGTAGTATCT- 
CATTCGTGTAGTCGTCGCTCAGCTGGCTGGTGCCAACCCCGTCACCGACGCTCCNTATCGTANTNCTCTTATCACCGTAACCACTACGCC- 
GCACACNCGTACGNTCAACAGTGTGCGGTACATCTATGTGCATCGTCNAANCTNTGACGCCGTACGTCTNAAATGATTNCGAACCCGNG- 
GTTTTNANATCCAAAGTCAACTTTNCGTACCGAANCTAGTNNNNNAGTCACTAAAATANANTAANNNN
ins-16 NNNNNNNNNNNNNNNNNNGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN  
NNNNNNNNNNNNNNGNNNNNNNNNNNNNNNNNNTNNNNNNNNNNNNNNACNNNNNGNNNNNCANANNNCGCNNN 
NNNNNNNAAAAAGNNNCACAGNNNNACGTNNGAGCTCCCGGCCANGAATNNCCGGCGCAAAAACTGACAGTGTGAG- 
GAGGCAGGCAAGAATTGGTAGGCTTTGCATGCGGCCGCCACCGCGGTGGAGCTCGAATTCATCGATGATATCAGATCTGCCG- 
GTCTCCCTATAGTGAGTCGTATTAATTTCGATAAGCCAGGTTGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGC- 
GAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGC- 
CAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATC- 
GACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCT- 
GT TCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCT- 
CAGTTCGGTGTAGGTCGTTCGCTCCNAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAAC- 
TATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCANANCGAGGTATG- 
TANGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACNGCTACNCTAGAAGANAGTATTTGGTATCTGCNCTCTGCTGAAGC- 
CAGTTACNTTCNNAAAANANTTGGNAGCTCNNGNTNNNGNNNNAAACNCNNTNGNANCNNNNNTTTTNNNNNANNCAGCNNA 
NNNCNCGCNNNAAAANNNNNNAGANNNNNNTNGATNNNTNNTNNNNNNNNNANNNTNNNNNNNNNAAANNNNNNNNNNNG- 
NATTNNNNNNNNNNNNNNNCNAAANNNNNTNNNNNNNNNNNNNNNNNNNNANNNNNNNNNNNNNNNNNNNNNNNNNNNNNGNNNN 
NNNNNNANNNNNNN
ins-30 GNNTAGNTATNTACATAGGNANGANGGNNTCNCTCTATTC’TTCTNCNNNGTTGAAGTTGAGGTTTTGANANTTTCCTCTANTTCACT- 
GCTCCTGTATATCAGNACGCTTCCCCTTTCTNTATTAATTTTTGCNTNACTTTCAGTTCCANCAAANTNNNNTNNNANNATCA- 
GATNGNNNNCCGTAAACATTTTNAGAGCCTCACGANCNNNGNGNTTCCGGNACCACAAACGGATNNGTTTTACGNTTCNTTGNCGA- 
CAATTTGATCCGCGTTNCCNGATGGCGATGNTCTCGTGGTGGCAGCGAGAAATGATCGGAGAAAGATCACNANAANGTCAAAAAACAAC- 
GAGGGTCTGTAAACTNGACAAAACCAGTATNTNNGNCNGCCCCCNNGNTGGAGCTCGAATTTCTCNCTGATGTCATATGTGCCAGTC- 
GCCCTATAGAGAGTCGTATTAATTTCGATAANNCAAGTAGGTTCCTCGATCANAGACNCNNTGTGATCGGTCGTTNGGCNGCTGGTAGCG- 
GTATNANCCCACGCAAAGGTGNNAATACGGTTATCCACCCAATCATNGNATAACGCANNNNNGAACATGTGNGCTAAAGGCCAACATNNT- 
GCCACCAACCGNAAANNNGACCNNNNNNTCGCNNNNNCNACTANNNNCCNNCCCNAAGACNNNCATNNNNTAANCCNNNNNCNGNNNC 
AGGTGGTGCANNANNCNNNNCNNNNNNANNCNCNTGGCCCACACCTCCGNNNCCGCTTNGNCCCTC
Supplementary Table 1.5. RNAi clone DNA sequencing. DNA identification sequence reads for RNAi E. coli 
clones selected for additional screening rounds.
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CHAPTER 2:
Caenorhabditis Sieve: A Low-tech Instrument and Methodology for Sorting Small Multicellular Organisms2
2 Citation: Hunter, S., Maulik, M., Scerbak, C., Vayndorf, E., Taylor, B.E. Caenorhabditis Sieve: A low-tech
Instrument and Methodology for Sorting Small Multicellular Organisms. Journal of Visualized Experiments. (137), 
e58014, DOI: 10.3791/58014 (2018).
2.1 ABSTRACT:
Caenorhabditis elegans (C. elegans) is a well-established model organism used across a range of basic and 
biomedical research. Within the nematode research community, there is a need for an affordable and effective way 
to maintain large, age-matched populations of C. elegans. Here, we present a methodology for mechanically sorting 
and cleaning C. elegans. Our aim is to provide a cost-effective, efficient, fast, and simple process to obtain animals 
of uniform sizes and life stages for their use in experiments. This tool, the Caenorhabditis Sieve, uses a custom-built 
lid system that threads onto common conical lab tubes and sorts C. elegans based on body size. We also demonstrate 
that the Caenorhabditis Sieve effectively transfers animals from one culture plate to another allowing for a rapid 
sorting, synchronizing, and cleaning without impacting markers of health, including motility and stress-inducible 
gene reporters. This accessible and innovative tool is a fast, efficient, and non-stressful option for maintaining C. 
elegans populations.
2.2 INTRODUCTION:
The nematode worm, Caenorhabditis elegans, is a premier model organism. In addition to the straightforward and 
controlled nature of their cultivation in the laboratory, their entire genome is sequenced1 and the developmental fate 
of each cell is known2. Due to these features, C. elegans is a widely used model organism for genetic studies. 
However, along with these beneficial characteristics come some challenges for researchers. Due to their rapid 
generation time, C. elegans populations can quickly run out of food and/or become mixed populations with multiple 
generations and developmental stages present at once. Thus, experiments performed on solid nematode growth 
media (NGM) require researchers to physically move animals to fresh plates before the bacterial food source 
depletes and new larvae develop. This can be tedious as a frequent transferring of the animals is required to prevent 
the experimental populations from becoming mixed with offspring generations. Still, some experiments require both 
large numbers of animals and extended time points (e.g., DNA or RNA extraction in adulthood). This compounds 
the challenges of accurately maintaining a synchronized population and transferring large numbers of animals.
Current methods of transferring C. elegans cultured on NGM are picking or washing the animals from plate to plate; 
chemically treating the animals (e.g., with the DNA replication inhibitor fluorodeoxyuridine or FUDR); or using 
flow cytometry to sort the animals in multi-well plates. Picking involves the use of a hand tool, made with either a 
thin platinum wire or an eyelash, to manually transfer individual or multiple animals3,4. This method is accurate but 
requires both skill and time and is a limitation for studies involving large numbers of animals. Picking may also be 
physically damaging and stressful to the animals by potentially subjecting individuals to unnatural and inconsistent 
amounts of disturbance and force. Washing involves rinsing a culture dish with a buffer solution and transferring the 
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solution with the animals via glass Pasteur pipette to a new culture plate. This method is rapid and efficient but is 
not accurate as multiple generations and developmental stages of animals are transferred in bulk. Chemical 
treatments, such as FUDR, can be dissolved in the culturing media to prevent the production of offspring through 
blocking any DNA replication, and thus, the gamete production and egg development. While effective, this method 
must be applied after developmental maturation so as to not disrupt the normal developmental processes, and this 
means that there is still a requirement to transfer the animals prior to its administration3. This method also influences 
multiple cellular signaling pathways, resulting in noticeable effects on the animals as they age (e.g., a lifespan 
extension or an altered proteostasis) depending on the strain of C. elegans used5-10. Flow cytometry methods 
automatically sort and transfer individual C. elegans from one multi-well plate to another11. While this method is 
very effective and efficient, flow cytometry equipment is prohibitively expensive and inaccessible to many 
researchers. An alternative to transferring animals is to use mutant models that are temperature sensitive, such as fer- 
15 and fem-1, which become sterile with temperature adjustment12. While using mutant animals is useful in some 
situations, these specific strains grow slower than wild-type animals and they rely on an altered genome, serving as 
poor representatives for aging or healthy worms. In addition, the reliance on a temperature shift to induce sterility 
also results in the absence of a static environment, and temperature changes have been readily shown to influence 
gene expressions13-15. Research groups have previously published techniques describing the use of a mesh to filter C. 
elegans by size16. However, we were unable to find previous work testing for any changes in the overall health 
outcomes that may be associated with the use of such filters.
There is, thus, a need within the C. elegans research community for an affordable, efficient, rapid, and accurate 
method for transferring large numbers of animals between culture plates. We have developed an improved, 
accessible piece of equipment (named the Caenorhabditis Sieve) and an associated protocol for its manufacture and 
operation that meets the needs of the C. elegans research community. Herein, we share the design of the 
Caenorhabditis Sieve and methods for its use, and we demonstrate that its use does not impact the health or any 
common stress markers when compared to standard manual picking and a treatment with the commonly-used, 
fertility-restricting chemical FUDR.
2.3 PROTOCOL:
2.3.1 Caenorhabditis Sieve Construction and Use
2.3.1.1 Construction protocol
2.3.1.1.1 Acquire 2 lids from 50 mL conical tubes (Figure 2.1A).
2.3.1.1.2 Remove the center area inside the inner lip of the lids (when viewed from the bottom, Figure 2.1B) using a 
Bunsen burner and a hot metal probe or a soldering iron or stepped drill bit.
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Note: Using heat to cut the plastic lid is preferable to a blade because there is less risk of injury.
2.3.1.1.3 Clean and sand the cut edges and top the surface with a curved file or a rotary grinding tool (e.g., Dremel). 
See Figure 2.1C.
2.3.1.1.4 Cut the circle of the monofilament mesh to the appropriate diameter (Figure 2.1D). For this, trace a lid 
onto a monofilament nylon mesh sheet and cut just inside the line drawn.
2.3.1.1.5 Cut grooves/slashes into the top surface of the lids to enhance the adhesion of the two lids when glue is 
applied to the plastic (Figure 2.1E).
2.3.1.1.6 Clean the lids with ethanol and let them dry.
2.3.1.1.7 Apply cyanoacrylate glue to the top surface of both lids, keeping to the outer edge.
Note: A little glue goes a long way.
2.3.1.1.8 Lay the monofilament mesh, according to Table 2.1, on one glued lid (Figure 2.1F). Place the second lid 
inverted on top of the mesh; both lids must have their tops together. Press firmly together (Figure 2.1G). Ensure that 
the mesh is taut.
Note: As a safety measure, use tweezers to place the mesh on the lids.
2.3.1.1.9 Once the initial layer of glue has dried, apply a ring of cyanoacrylate glue around the outer gap between the 
lids. Be generous as this adds integrity and prevents any peeling apart or leaking.
2.3.1.1.10 Label the filter with the mesh pore size of the monofilament mesh.
Note: Here, we use two mesh pore sizes—20 μm and 50 gm.
2.3.1.2 Use protocol
2.3.1.2.1 Pre-wet the sieve.
2.3.1.2.1.1 Pipette a saline solution, such as M9 [5 g of NaCl, 6 g of Na2HPO4, 3 g of KH2PO4, 1 L of ultrapure H2O, 
and 1 mL of MgSO4 (1 M)]17, through the center of the sieve until a droplet forms, condenses, and drips off the 
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center of the filter bottom (Figure 2.2A). Optionally, apply a lint-free wipe (e.g., Kimwipe) to the bottom to shape 
or spread a moisture droplet on the mesh.
2.3.1.2.1.2 Place the sieve over a 50 mL conical tube. Label the tube as 'Waste tube' (Figure 2.2B).
2.3.1.2.2 Wash a population of C. elegans off an agar plate.
2.3.1.2.2.1 Wash the plate with the M9 buffer and place the worm-containing medium on the topside of the 
monofilament mesh 1 mL at a time (Figure 2.2C). Make sure to operate in the center of the mesh. Wash all worms 
from the plate.
Note: Typically, 3 mL of M9 for a 60 mm plate is sufficient.
2.3.1.2.2.2 To minimize the number of worms lost in pipetting, use a glass Pasteur pipette to move the worms off the 
plate and onto the mesh center (repeat as needed).
2.3.1.2.2.3 Rinse the filter with the M9 buffer from the top. Again, make sure to operate in the center of the mesh 
and rinse all worms in that area. Wash as many times as necessary to ensure that all the bacteria and smaller worms 
have passed through the mesh.
2.3.1.2.3 Harvest the size-matched animals from the sieve.
2.3.1.2.3.1 Attach a new 50 mL conical tube to the top of the sieve, with the adult worms from step 1.2.2.3 facing 
the inside of the new collection tube (Figure 2.2D).
2.3.1.2.3.2 Remove the first tube (waste tube) and quickly flip over the sieve and new tube to keep the droplet from 
migrating (Figure 2.2E).
Note: If sterility is not required, use a lint-free wipe (e.g., Kimwipe) to wick fluid from bottom of the mesh prior to 
flipping.
2.3.1.2.3.3 Rinse the mesh with M9 into the new 50 mL tube from the new topside (Figure 2.2F). Again, operate in 
the mesh center and maintain a droplet on the underside of the mesh.
2.3.1.2.3.4 Allow the worms to settle or gently spin them down (e.g., < 16 x g) for approximately 1 min (Figure 
2.2G).
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2.3.1.2.3.5 Aspirate the buffer solution from the pellet of worms, ideally down to > 0.5 mL, or remove as much fluid 
as possible without disturbing the pellet.
2.3.1.2.3.6 Pipette the worms using a glass Pasteur pipette onto an NGM plate and let them dry. Space multiple 
droplets out on a new plate so they dry faster (Figure 2.2H).
2.3.1.2.4 Clean the sieve.
2.3.1.2.4.1. Rinse the sieve gently and thoroughly with ethanol and reverse-osmosis water. Let it dry.
2.3.1.2.4.2 Store it in a clean container for indefinite future use.
2.3.1.2.4.3 Discard it when the mesh develops a "sag" appearance.
2.4 VALIDATION OF CAENORHABDITIS SIEVE SORTING METHOD:
2.4.1 General maintenance
2.1.1. For all experiments, culture worms on a standard Nematode Growth Media17 (1 L of NGM consists of 2.5 g of 
peptone, 17 g of agar, 3 g of NaCl, 975 mL of double-distilled water, 1 mL of 5 mg/mL cholesterol, 1 mL of 1 M 
CaCl2, 1 mL of 1 M MgSO4, 25 mL of 1 M KHPO4, and 0.5 mL of 100 mg/mL streptomycin) at 25°C.
2.4.2 Experimental treatment administration
2.4.2.1 Compare the three treatment groups: pick, fluorodeoxyuridine (FUDR), and Caenorhabditis Sieve.
2.4.2.1.1 For the FUDR treatment group, add 100 mg/mL FUDR to the NGM media to a final concentration of 100 
μM to prevent any progeny production, and transfer the worms every other day to a fresh NGM plate to avoid food 
depletion.
2.4.2.1.2 For the pick group, select and transfer the worms manually using a platinum loop.
2.4.2.1.3 For the Caenorhabditis Sieve treatment group, follow step 1.2 and pipette the worms onto an NGM plate.
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2.4.3 Caenorhabditis Sieve percentage yield
2.4.3.1 To quantify how effective the sieve is at sorting C. elegans, grow age-synchronous N2 animals to day 1 of 
adulthood at 25°C (i.e., 48 h after egg laying) and then transfer them by picking them to fresh NGM plates (totaling 
N = 50 or N = 100 animals per treatment group).
2.4.3.2 After 24 h of recovery, transfer the population to new NGM plates with the Caenorhabditis Sieve following 
the above protocol (see step 1.2) and count the number of successfully transferred animals.
2.4.3.3 Calculate the percentage yield as the ratio of the number of animals transferred in comparison to the starting 
number at the beginning of the transfer multiplied by 100 (%).
2.4.4 Healthspan assays
Note: Score healthspan parameters of the motility class, the pharyngeal pump rate, and both the anterior and the 
posterior gentle touch response on days 2, 4, 6, and 8 of adulthood for age-synchronized N2 animals maintained at 
25°C.
2.4.4.1 Motility tracking
2.4.4.1.1 Assign motility scores based on a class-based system (classes A, B, and C) following the methods of 
Herndon et al.18. Compare the effects of the three experimental groups using an ordinal logistic statistics model in 
statistical analysis software.
Note: Class A individuals move spontaneously in a normal, sinusoidal pattern. Class B individuals move in 
markedly non-sinusoidal movements and may require prodding to encourage movement. Class C individuals move 
their head and/or tail in response to prodding but are unable to move across the agar.
2.4.4.2 Pharyngeal pump rate
2.4.4.2.1 Count the grinder movement of the animal's terminal pharyngeal bulb visually under a stereomicroscope at 
a 600X final magnification for 1 min.
2.4.4.2.2 Conduct a statistical analysis with a one-way ANOVA with a = 0.05 and Bonferroni post-tests with a = 
0.05.
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2.4.4.3 Touch response
2.4.4.3.1 Record a gentle touch response and compare between the three treatment groups. Perform the assays based 
on the methods described by Calixto et al.19.
2.4.4.3.2. Record the anterior and posterior touch response by gently stroking an eyelash pick perpendicularly across 
the tail or the head (5x each, alternating head and tail) of the animals.
2.4.4.3.3 Score any movement in the opposite direction of the stroke as 1 point on a scale of 0 to 5 for both the 
anterior and the posterior response.
2.4.4.3.4 Conduct statistical analysis with a one-way ANOVA with a = 0.05 and Bonferroni post-tests with a = 0.05.
2.4.5 Fecundity assay
2.4.5.1 To determine the use of the Caenorhabditis Sieve's impact on reproduction, grow age-synchronous N2 
animals to day 2 of adulthood at 25°C.
2.4.5.2 60 h after egg lay, transfer animals to new NGM plates with either a platinum pick or the Caenorhabditis 
Sieve and give them 4 h to recover (dry the sieved plates for 20 - 30 min).
2.4.5.3 After recovery, individually plate the animals via an eyelash pick to NGM plates, give them 24 h to lay eggs, 
and remove the animals. Allow the progeny on each plate to develop under normal conditions at 25°C for another 24 
h.
Note: An eyelash pick is a human eyelash secured to the end of a Pasteur pipette with nail polish and sterilized with 
ethanol.
2.4.5.4 Count the number of viable F1 generation individuals. Perform a statistical analysis using a T-test with a = 
0.05.
Note: Viable offspring are considered to be eggs that successfully hatch and begin their development through the 
regular larval cycles.
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2.4.6 Fluorescent reporter stress response assays
2.4.6.1 Perform three commonly used fluorescent reporter assays to detect potential markers of stress: a DAF- 
16::GFP translocation into the nuclei of cells in a strain [TJ356- zIs356 (pDAF-16::DAF-16-GFP;rol-6)]20; an hsp-
16.2 expression [TJ375- gpIs1 (hsp-16.2p::GFP)]21; and a sod-3 expression [CF1553-muIs84([pAD76]sod- 
3p::GFP+rol-6[su1006])]22.
2.4.6.2 For each assay, culture age-synchronous animals from the three treatment groups at 20°C and examine them 
at day 3 of adulthood: use a negative control (on a daily basis, transfer a group of animals manually with a platinum 
pick), a positive control (on a daily basis, transfer a group of animals manually with a platinum pick plus an 
established stressor), and the Caenorhabditis Sieve (pass the animals through the sieve and allow them to recover 
for 30 min on NGM just before imaging).
2.4.6.3 In the DAF-16::GFP assay, heat shock the positive control animals at 37°C for 30 min before imaging20. For 
the hsp-16.2 assay, heat shock the positive control animals for 90 min, 20 h before imaging21. For the sod-3 assay, 
treat the positive control animals with 100 mM paraquat for 4 h before imaging22.
2.4.6.4 Harvest the worms immediately with an eyelash pick and mount them to a coverslip with 1 μL of a 36% 
poloxamer 407 surfactant solution to immobilize the worms.
2.4.6.5 Sandwich the mounted worms with another coverslip. Mount the two coverslips to a standard glass 
microscopy slide and image the worms using an 8X magnification on an inverted fluorescent microscope (for an 
overall magnification of 80X) and a constant exposure with a FITC filter.
2.4.6.6 To detect any differences between the three groups in the DAF-16 : :GFP assay, categorize the animals based 
on the location of the DAF-16::GFP reporter (nuclear if the reporter translocated to nuclei, cytosolic if the reporter 
located in cytosol, and intermediate if the reporter located in both nuclei and cytosol).
2.4.6.7 Compare the results using an ordinal logistics statistical model in statistical analysis software. For the hsp-
16.2 and the sod-3 expression assays, use a one-way ANOVA with a = 0.05 and Tukey's post hoc tests with a = 0.05 
to compare the total fluorescence of the head region.
2.5 REPRESENTATIVE RESULTS:
The Caenorhabditis Sieve consists of 2 screw caps, securing an area of woven nylon monofilament mesh smaller 
than the body diameter of the desired developmental age, used to extract live populations of organisms using a 
simple washing technique. It attaches to standard conical tubes and uses the mesh screen to mechanically sort 
animals by body diameter, leaving the desired animals in the tube ready for further maintenance and 
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experimentation (e.g., transfer or genetic harvest). A gentle manual washing with the Caenorhabditis Sieve is quick, 
approximately 5 min per 60 - 100 mm plate, and the organisms are easily recovered from the mesh.
Percentage yield of animals following Caenorhabditis Sieve use:
To establish the percentage yield of the Caenorhabditis Sieve, devices were tested with both 20 gm and 50 gm pore­
size meshes on adult animals. A mean yield of a > 90% successful animal transfer was achieved for both mesh sizes 
tested (Table 2.1).
Monofilament mesh with different size gaps may be used to separate animals of different life stages. Mesh with 20 
gm gaps is appropriate for washing away developing embryos and larval stages smaller than the fourth larval stage, 
retaining the latter (L4; with an average body diameter of 32 gm) and any animals in later life stages, while mesh 
with 50 gm gaps will allow all other life stages aside from adults (with an average body diameter of 70 gm) to be 
washed away (Table 2.2).
Caenorhabditis Sieve use does not impact healthspan metrics
Motility: In C. elegans the normal sinusoidal movement (i.e., motility) declines with age18 and is a marker of 
overall health. To determine if the Caenorhabditis Sieve influenced motility, motility scores were compared for 
pick, FUDR, and Caenorhabditis Sieve treatment groups on days 2, 4, 6, and 8 of adulthood. All the animals across 
every group (N = 10/group) exhibited normal and spontaneous movement patterns (Class A) at multiple ages 
throughout adulthood (days 2, 4, 6, and 8 of adulthood; p > 0.05 for multiple comparisons on all days, Figure 2.3).
Pharyngeal pump rate: The ability of C. elegans' pharyngeal muscles to pump declines with age and is another 
biomarker of healthspan23. To determine if the Caenorhabditis Sieve influenced the animals' pharyngeal pump rate, 
pick, FUDR, and Caenorhabditis Sieve treatment groups were compared on days 2, 4, 6, and 8 of adulthood (n = 8 
to 10 per group). There was a significant difference between the animals that underwent the picking and FUDR 
methods on days 6 (p < 0.001) and 8 (p < 0.001). Also, there was a significant difference between the sieve and 
FUDR groups on days 6 (p < 0.001) and day 8 of adulthood (p < 0.001). However, there was no statistically 
significant difference between the pick and the Caenorhabditis Sieve groups for any day (p > 0.05, Figure 2.4), 
indicating that the sieve does not impact this measure of healthspan.
Gentle touch response: Response to mechanical stimulus is a physiological marker to assess aging or general 
health24,25; thus, the impact of different transfer methods on both the anterior and the posterior gentle touch 
responses were tested. There was no statistically significant difference between the pick, FUDR, and Caenorhabditis 
Sieve treatment groups (n = 8/group), either anteriorly or posteriorly, for any day of testing (p > 0.4 for all 
comparisons; Figures 2.5A and 2.5B).
Fecundity: To establish whether or not the Caenorhabditis Sieve influenced the amount of viable progeny produced 
by C. elegans, the individual offspring produced in a 24 h period during day 3 of adulthood was counted and 
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compared (n = 20 to 22 per group). The use of the Caenorhabditis Sieve did not significantly impact the number of 
progeny produced when compared to a pick treatment group (p = 0.61, Figure 2.6).
Molecular reporter assays:
DAF-16 nuclear translocation: In C. elegans, the activation of the transcription factor DAF-16 is associated with 
increased stress resistance26. The nuclear localization of DAF-16 was examined in a transgenic nematode strain 
TJ356, which expresses DAF-16 fused to a green fluorescent protein (DAF-16::GFP)20. Under normal growth 
conditions, DAF-16::GFP is localized primarily in the cytosol, but under various stressors (e.g., heat stress), it is 
rapidly translocated into the nucleus20. To test the impact of sorting with the Caenorhabditis Sieve on DAF-16 
translocation, DAF-16::GFP localizations were compared in age-matched day-5 adults in a positive control group 
(heat stress), a negative control group (manual transfer via pick), and a Caenorhabditis Sieve treatment groups (n = 
10/group). The transfer with the Caenorhabditis Sieve did not affect the nuclear translocation of DAF-16::GFP, and 
showed a similar phenotype to the negative control animals (p > 0.05, Figure 2.7).
hsp-16.2 reporter: Small heat shock proteins like HSP-16.2 are biomarkers of a stress response, and they are highly 
expressed during an exposure to heat shock or oxidative stress agents21,27. The TJ375 strain has a GFP reporter gene 
fused with an hsp-16.2 promoter that is not active under normal conditions21. However, after an exposure to a heat 
shock, HSP-16.2 protein expression is induced, and the animals display high levels of GFP expression21. To test the 
involvement of the Caenorhabditis Sieve on an HSP-16.2-mediated stress response, the fluorescence density in the 
pharynx region (n = 10 animals/group) of age-matched animals was compared in day-5 adults between a positive 
control group (heat stress), a negative control group (picking), and a Caenorhabditis Sieve treatment group. The 
transfer with the Caenorhabditis Sieve did not significantly induce the expression of HSP-16.2::GFP (hsp-16.2::gfp) 
when compared to the negative control (p > 0.05, Figure 2.8).
sod-3 reporter: In C. elegans, the anti-oxidant gene that codes for superoxide dismutase 3 (SOD-3) is up-regulated 
during oxidative stress28. The C. elegans strain CF1553 expresses green fluorescent protein (GFP)-labeled SOD-3 
promoter, whose expression is induced by oxidative stressors, such as paraquat5. To test the involvement of the 
Caenorhabditis Sieve sorting on the antioxidant response in C. elegans, the fluorescence density in the head region 
of age-matched day-5 adults was compared between a positive control population (100 μM paraquat treatment), a 
negative control population (manual picking), and a Caenorhabditis Sieve-transferred population. The transfer with 
the Caenorhabditis Sieve did not significantly induce the expression of sod-3::gfp when compared to the negative 
control (p > 0.05, Figure 2.9).
2.6 DISCUSSION:
Herein, we introduced the design and use of the accessible, effective Caenorhabditis Sieve as a tool for sorting and 
maintaining C. elegans. This tool has several advantages to manually picking individual animals, washing 
populations, chemical treatments (e.g., FUDR), and more expensive methods of segregating animals. First, the 
60
Caenorhabditis Sieve efficiently and quickly (less than 20 min) sorts progeny from large mixed populations of 
animals (Table 2). Also, the use of the tool has no detectable toxic effects on the animals' healthspan (Figures 3 - 
6), does not induce well-described genetic stress reporters (Figures 7 - 9), and reduces the amount of foreign 
chemical that could influence the applied treatment to the culture plates or any molecular assay thereafter. Its ease of 
use is a significant advantage; a researcher at any stage in their education can be trained to use it (Figures 1 and 2; 
Protocol).
The materials required for the fabrication and use of the sieve (e.g., pipettes, buffers) are readily available in 
standard research laboratories; thus, if broken, the Caenorhabditis Sieve is not expensive to replace or repair 
(Supplemental Table 2.3). The self-constructed nature of the Caenorhabditis Sieve allows it to be a versatile tool: it 
can be constructed with mesh sizes appropriate for different C. elegans developmental stages and phenotypes. The 
Caenorhabditis Sieve may also be used in assays conducted in other nematode species or when isolating small 
organisms, provided the appropriate mesh size is used upon manufacture.
In addition to the benefits this tool provides for C. elegans population maintenance, the Sieve may be used to clean 
animals before their use in other experimental applications. For example, with the development of microfluidics to 
conduct C. elegans research comes the issue of chip use and cleaning. Depending on the amount of bacteria attached 
to the animals, special precautions need to be taken so as not to clog the microfluidic chip, rendering it unusable29. 
Often when C. elegans are transferred to a microfluidic chip, residue from the bacterial lawn is brought with them. 
This residue can and does clog the microfluidic channels, making the chip malfunction, which then requires cleaning 
or replacement. The device constructed in this protocol offers a method for not only harvesting synchronized 
animals for microfluidics, but also for cleaning the animals prior to their insertion into a microfluidic device. By 
removing the debris and bacterial residue, taken up when collecting animals, the microfluidic channels are less 
prone to malfunction, thus increasing the operational life of individual chips and the subsequent throughput of 
research being conducted with them.
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2.10 FIGURES AND TABLES:
Figure 2.1. Caenorhabditis Sieve construction. The progression of the ‘do-it-yourself’ manufac­
ture of the tool is shown. These panels show (A) two 50 mL conical tube caps (B) whose centers have 
been removed, (C) cut edges smoothed, and (D - F) who are fitted with monofilament mesh correspond­
ing to the desired life stage of C. elegans (see Protocol for details). (G) The completed sieve is also shown.
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Figure 2.2. Step-by-step image representation of Caenorhabditis Sieve use. (A) The sieve is pre-wet with a 
drop of M9 solution, and (B) fit on top of a 50 mL conical tube. (C) 1 mL of M9 solution with worms is pipet­
ted on the topside of the sieve, (D) a 50 mL conical tube is placed on top of the sieve with the worms facing 
the inside of the tube, and (E) the sieve with a newly attached upper tube is quickly flipped over. (G) The sieve 
is rinsed with M9 carrying the desired animals into the new 50 mL tube and the worms are allowed to settle 
by gravity to the bottom of the tube. (H) The worms are pipetted and placed as droplets on a fresh NGM plate.
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Figure 2.3. Caenorhabditis Sieve did not impact mo­
tility throughout lifespan. This figure shows the motil­
ity class distribution of animals at days 2, 4, 6, and 8 
of adulthood for pick, FUDR, and Caenorhabditis Sieve 
treatment groups, all days tested had the same distribu­
tion. Class A animals moved normally and spontane­
ously, class B animals moved abnormally and may have 
required prodding, and class C animals were unable to
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Figure 2.4. Caenorhabditis Sieve use did not impact 
pharyngeal pumping throughout the lifespan. This 
figure shows the pharyngeal pump rates of pick, FUDR, 
and Caenorhabditis Sieve treatment groups, compared 
on days 2,4, 6, and 8 of adulthood. The asterisks denote 
a significance between the pick, sieve, and FUDR treat­
ment groups for the days specified (*** p < 0.05). There 
was no difference between the Caenorhabditis Sieve and 
the pick group (p > 0.05). Two replicates (N = 10 ani-
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Figure 2.5. Caenorhabditis Sieve use did not impact anterior touch response throughout lifespan. These 
panels show (A) the anterior and (B) the posterior touch response count of pick, FUDR, and Caenorhabditis 
Sieve treatment groups compared on days 2, 4, 6, and 8 of adulthood. Two replicates were conducted with N 
= 10 for each treatment group and compared with a one-way ANOVA and a Bonferroni post-test (p = 0.4 and 
p = 0.9 for anterior and posterior, respectively). The bars represent the mean ± the standard error of the mean.
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Figure 2.6. Caenorhabditis Sieve did not impact the 
amount of viable progeny on day 3 of adulthood. 
This figure shows the viable progeny from 24 h egg-
laying period, spanning day 3 of adulthood for parent 
animals. The bars represent the mean ± the standard er­
ror of the mean. N = 20 - 22 animals from at least two 
separate biological replicates per treatment group. The 
treatment groups are compared with a t-test, (p > 0.05).
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Figure 2.7. Caenorhabditis Sieve did not affect nuclear translocation of DAF-16::GFP. These panels show rep­
resentative images of the DAF-16 translocation of (A) a heat shock group (the positive control), (B) a pick group 
(the negative control), and (C) a Caenorhabditis Sieve treatment group. Scale bars represent approximately 50 pm. 
(D) The animals in the positive control group displayed an activation of the DAF-16 nuclear translocation. The Cae­
norhabditis Sieve did not induce a nuclear translocation and displayed cytosolic fusion protein similar to the animals 
in the negative control group. N = 10 animals per treatment group from at least three separate biological replicates. 
The treatment groups were compared with a one-way ANOVA and a Tukey’s post hoc test. The scale bar is 100 pm.
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Figure 2.8. Caenorhabditis Sieve did not affect the ex­
pression of hsp-16.2::gfp. The HSP-16.2 expressions 
(in arbitrary fluorescence units) of a heat shock group 
(the positive control), a pick group (the negative con­
trol), and a Caenorhabditis Sieve treatment group are 
compared. The asterisks denote a high expression of 
hsp-16.2::gfp for the positive control group which was 
significantly different from the other treatment groups 
(*** p<0.05) The Caenorhabditis Sieve did not af­
fect the hsp-16.2::gfp expression and displayed fluores­
cence intensities similar to animals in the negative con­
trol group (p > 0.05). Three replicates were conducted 
with N = 10 for each treatment group and compared 
with a one-way ANOVA and a Tukey’s post hoc test.
72
Figure 2.9. Caenorhabditis Sieve did not affect the 
expression of sod-3::gfp. The SOD-3 expressions 
(in arbitrary fluorescence units) of a 100 pM paraquat 
group (the positive control), a pick group (the nega­
tive control), and a Caenorhabditis Sieve treatment 
group are shown. The asterisks denote a high expres­
sion of sod-3::gfp for the positive control group which 
was significantly different from the other groups (*** 
p < 0.05). The Caenorhabditis Sieve did not affect 
the sod-3::gfp expression and displayed fluorescence 
intensities similar to the animals in the negative con­
trol group (p > 0.05). Three replicates were conducted 
with N = 10 for each treatment group and compared 
with a one-way ANOVA and a Tukey’s post hoc test.
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Table 2.1. Percentage yield of mesh sizes.
This table shows the results of a 20 μm device 
tested with N = 50 adults for 3 replicates and 
a 50 pm device tested with N = 50 adults for 
2 replicates and with N = 100 for 3 replicates.
Mesh size N=50 N=l00
20 pm 95.33% NA
50 μm 99.00% 93.33%
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Table 2.2. Mean body diameter. This 
table displays the mean body diameter 
acquired by averaging 3 measurements 
equally spread across each worm for 
15 animals at each measured life stage.
Mesh Size Dev. Stage Body Diameter
20 pm Larval Stage 4 ~35 μm
50 μm Day 1 Adult ~70 μm
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Name of Material/ 
Equipment
Company Catalog Number Comments/Description
Safety glasses Uline S-21076
Protective heat resistant 
gloves Grainger
Item # 3ATI7
Mfr. Model # 3AT17
Catalog Page # 1703
50 mL conical tubes Falcon 14-432-22 Tubes and lids will be used
Synthetic nylon mesh Dynamic Aqua-Supply Ltd. NTX20 and NTX50
Select pore size for 
application
Cyanoacrylate glue Scotch Super Glue Liquid SADI 14
Pliers Vampliers VMPVT-001-8 Used to hold lids while cutting
Dremel tool with circular 
file Lowe’s
Item # 525945 
Model# 100-LG
Used to clean hole that 
was cut
FuDR Sigma F0503
M9 Chemical (NaCl, 
Na2HPO4, KH2PO4,
 MgSO4)
Sigma S7653, RES20908-A7, 1551139, M7506
NGM plate chemicals 
(Bactopeptone, Agar, 
KH2PO4, K2HPO4, 
CaCl2,Cholesterol, Strep­
tomycin)
BD Biosciences (bacto­
peptone) , Lab express 
(agar), Sigma (rest)
BD bioscience 211677, 
Lab Express 1001, Sig­
ma 1551139, 1551128, 
C1016, C8667, S6501
Pluronic® F-127 Sigma P2443
Paraquat dichloride hy­
drate Sigma 36541
Step drill bit Huele B06Y25PFMZ Other brands will work so long as they cut up to 1 in
Supplemental Table 2.3. List of material and supply. List of materials and supplies used to construct the Cae­
norhabditis Sieve and proof-of concept experiments.
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GENERAL CONCLUSION:
Insulin Ligands Influence Morphology of Mechanosensory Neurons
The results presented in Chapter 1 show that ILPs influence the morphology of mechanosensory neurons in C. 
elegans. There was inconsistency in the results, in that the second round of RNAi did not produce changes in 
neuronal aberrations similar to the first and third rounds. The second round of RNAi resulted in a single change in 
Neurite Branches while the first and second rounds resulted in multiple changes in multiple Somatic Outgrowth 
types. The similarity in the outcome of rounds 1 and 3 provides some support for the hypothesis, knockdown of 
similar ILP subfamily members will result in similar phenotypic aberrations in neurons, as the ILP re-screen 
candidates were primarily from the p sub-family of ILPs, and knockdown of those p sub-family members produced 
similar shifts in neuronal aberrations. Of emphasis from this study, is that these identified ILPs are considered 
important for promoting neuronal aberrancy to that seen in what is considered normal levels in regular, aging 
morphology. Their knockdown was causative of the observed decrease in morphological aberrations. This is most 
likely due to agonist behavior at the DAF-2 receptor to which they bind. This agonist-like behavior observed in the 
chosen ILPs is plausible as the absence of these possible agonists would produce a decrease in DAF-2 signaling and 
subsequent increase in DAF-16 translocation, which has been shown to decrease neuronal aberrancy in 
mechanosensory neurons17. Knockdown of antagonist ILPs, on the other hand, would produce no change in IR 
activity as the agonist ILPs out-compete them already, or would increase receptor activity from agonist ILP behavior 
going unchecked. This unchecked agonist behavior causing an inhibition of the DAF-16 pro-longevity transcription 
factor, and an increase in neuronal aberration28,30,32,39. Also, several p subfamily members are known to have agonist 
behavior on the DAF-2 receptor through dauer modulation, such as INS-2, INS-3, INS-4, INS-6, INS-7, and DAF- 
2828,32,33,59. Interestingly, two p sub-family ILPs are known to display antagonistic behavior, INS-133,34, the closest 
C. elegans homolog to human insulin, and INS-745. INS-7 displays both agonistic and antagonistic behavior 
depending on the observed outcome, such as dauer prevention27 or learning45, respectively. This variable role 
supports a context-based function of ILPs47, and the idea of a spatiotemporal “block-design” that is responsible for 
orchestrating overall ILP expression in specific tissues under specific environmental and cellular conditions35. This 
further highlights that more research is necessary on the ligand-receptor binding interaction to fully understand ILP 
signaling. Because of the experimental endpoint context and tissue specificity of ILP activity, understanding the 
direct binding activity of ILPs to the IR receptor and any inter-ILP binding competition would greatly contribute to 
understanding of how those context-specific activities are achieved. This understanding would fill in the gap at the 
start of the IIS pathway with elucidation of the molecular sterics of different ILPs on the IR binding sites. Molecular 
studies of more direct IIS pathway responses and mRNA expression levels over time are proposed to paint a more 
accurate picture of how the IR responds to individual ILPs and which ILPs will play long term roles in neuronal 
aging. The results presented in this study indicate specific ILPs, and the p subfamily in particular, to be responsible 
for maintaining normal mechanosensory neuron morphology. Therefore, these ILPs should be considered as starting 
points for future work that focuses on neuronal aging and neurodegeneration, and as potential candidates for further 
molecular study into ligand-receptor binding.
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Caenorhabditis Sieve: A Low-Tech Instrument and Methodology for Sorting Small Multicellular Organisms 
Results garnered from Chapter 2, show a successful introduction of a new technology designed for research 
laboratory use. The original goal of designing and producing a tool and accompanying protocol that is an affordable, 
efficient, rapid, and accurate alternative method for transferring large numbers of animals at particular 
developmental stages between culture plates was met. This is evidenced by the Caenorhabditis Sieve's adoption as a 
transfer methodology by other researchers in the shared laboratory space the device was designed in, for either 
transferring via its primary intent or cleaning C. elegans as per an alternative intended purpose. Even more evidence 
that the initial goals were met is the reproduction and implementation of the device in the research laboratory of Dr. 
Michael B. Harris at California State University, Long Beach, for use in an upstart newly established C. elegans 
laboratory. Along with this adoption by other researchers, was the frequent use of the Caenorhabditis Sieve in a 
teaching environment where several undergraduate researchers successfully used the device and protocol. These 
outcomes highlight the simplicity of comprehension and use by researchers with little laboratory experience or 
experience with the Caenorhabditis Sieve. They also bolster a broad reaching impact on the greater research 
community that this tool provides.
This novel technology and the ability it has to fill a gap in basic research tools through its simplicity, efficacy, and 
cost effectiveness allowed the parent university, University of Alaska Fairbanks, to file a patent and license the 
technology with the biomedical research company NemaMetrix for further research and development to bring the 
device to market and mass production in the hopes of advancing scientific progress.
Thesis Contributions
Both chapters 1 and 2 of this thesis contribute to the advancement of science. Chapter 1 identifies a list of ILPs that 
are responsible for the occurrence of normal age-related morphology changes in neurons. This list of ILPs and 
resulting data on the relative shifts in morphology changes, when the expression of each is individually knocked 
down, helps to clarify the role of those ILPs as either agonists or antagonists to the DAF-2 receptor. Chapter 1 also 
presents future research avenues to further understand IIS and its influence on neuronal aging and metabolic 
signaling overall. Chapter 2 introduced a new laboratory tool that facilitates the use of assays utilizing small 
organisms that would otherwise be unfeasible. Together, the application of the Caenorhabditis Sieve from chapter 2 
can be applied to the research avenues described in chapter 1 to acquire further knowledge on the IIS pathway. The 
Caenorhabditis Sieve can assist in the proposed genetic screen, using C. elegans daf-16::gfp reporter strain, by 
allowing for larger numbers of animals to be maintained for each RNAi treatment group. Additionally, by removing 
the tedious and time consuming process of hand transferring individual animals the proposed screen could be 
conducted in a smaller amount of time as animal transfer in different treatment groups would not need to be 
staggered over multiple days to account for transfer time. The Caenorhabditis Sieve can also assist in the proposed 
research of C. elegans ILP mRNA expression by allowing researchers to use and maintain the large numbers of C. 
elegans required for each group used for genetic material harvesting, and additionally by keeping those groups of C. 
elegans free of mixed population and bacterial genetic contamination. By using these thesis chapters in concert with 
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one another researchers can dig deeper into the mechanics and functionality of the IIS pathway. By facilitating these 
future research endeavors down the proposed paths, this thesis as a whole serves to contribute to the advancement of 
IIS understanding, and by direct extension, a better understanding of the aging process that underlies 
neurodegeneration.
81
82
BIBLIOGRAPHY:
1. Yankner, B., Lu T., Loerch, P. The aging brain. The Annual Review of Pathology: Mechanisms of Disease. (3),
41-66 (2008). DOI: 10.1146/annurev.pathmechdis.2.010506.0920442008
2. Bishop, N.A., Lu, T., Yankner, B.A. Neural mechanisms of ageing and cognitive decline. Nature 464 (7288), 
529-535 (2010). DOI: 10.1038/nature08983
3. Fjell, A.M., Walhovd, K.B. Structural brain changes in aging: courses, causes and cognitive consequences. 
Reviews in the Neurosciences. 21 (3), 187-221 (2010). PMID: 20879692
4. Knobloch, M., Mansuy, I.M. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Molecular
Neurobiology. 37 (1), 73-82 (2008). DOI: 10.1007/s12035-008-8018-z
5. https://www.alz.org/alzheimers-dementia/facts-figures
6. http://parkinson.org/Understanding-Parkinsons/Causes-and-Statistics/Statistics
7. http://www.alsa.org/about-als/facts-you-should-know.html
8. https://www.cdc.gov/DiseasesConditions/
9. Vilchez, D., Saez, I., Dillin, A. The role of protein clearance mechanisms in organismal ageing and age-related 
diseases. Nature Communications. 2014 (5), 5659 (2014).
10. Mattson, M. P., Chan, S. L., Duan, W. Modification of brain aging and neurodegenerative disorders by genes, 
diet, and behavior. Physiol. Rev. 2002 (82), 637-672 (2002).
11. Samuelson, A., Carr, C., Ruvkun, G. Gene activities that mediate increased life span of C. elegans insulin-like 
signaling mutants. Genes and Development. 21 (22), 2976-2994 (2007). DOI: 10.1101/gad.1588907
12. Kaletsky, R., Murphy, C. The role of insulin/IGF-like signaling in C. elegans longevity and aging. Disease 
models & mechanisms. 3 (10), 415-419 (2010). DOI: 10.1242/dmm.001040
13. Kannan, K., Fridell, Y. Functional implications of Drosophila insulin-like peptides in metabolism, aging, and 
dietary restriction. Frontiers in physiology. 4 (October), 288 (2013). DOI: 10.3389/fphys.2013.00288
83
14. Suh, Y. et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. 
Proceedings of the National Academy of Sciences of the United States of America. 105 (9), 3438-3442 (2008). DOI: 
10.1073/pnas.0705467105
15. Pan, C., Peng, C., Chen, C., McIntire, S. Genetic analysis of age-dependent defects of the Caenorhabditis 
elegans touch receptor neurons. Proceedings of the National Academy of Sciences of the United States of America. 
108 (22), 9274-9 (2011). DOI: 10.1073/pnas.1011711108
16. Tank, E., Rodgers, K.E., Kenyon, C. Spontaneous Age-Related Neurite Branching in Caenorhabditis elegans. 
The Journal of neuroscience: the official journal of the Society for Neuroscience. 31 (25), 9279-88 (2011). DOI: 
10.1523/JNEUROSCI.6606-10.2011
17. Toth, M. et al. Neurite Sprouting and Synapse Deterioration in the Aging Caenorhabditis elegans Nervous 
System. The Journal of neuroscience: the official journal of the Society for Neuroscience. 32 (26), 8778-8790 
(2012). DOI: 10.1523/JNEUROSCI.1494-11.2012
18. van Exel, E. et al. Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family 
study. Neurobiology of Aging. 35 (2014), 725.e7-725.e10 (2014). DOI: 10.1016/j.neurobiolaging.2013.08.014
19. Steen, E. et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in 
Alzheimer's disease- is this type 3 diabetes? Journal of Alzheimer's Disease. 7 (2005), 63-80. DOI: 10.3233/JAD- 
2005-7107
20. Gami, M.S., Wolkow, C. Studies of Caenorhabditis elegans DAF-2/insulin signaling reveal targets for 
pharmacological manipulations of lifespan. Aging Cell. 2006 (5), 31-37 (2006). DOI: 10.1111/j.1474- 
9726.2005.001888.x
21. Paradis, S., Ruvkun, G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 
PI3 kinase to DAF-16 transcription factor. Genes and Development. 12 (16), 2488-98 (1998). PMID: 9716402
22. Paradis, S., Ailion, M., Toker, A., Thomas, J., Ruvkun, G. A PDK1 homolog is necessary and sufficient to 
transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes and Development. 13 
(11), 1438-1452 (1999). DOI: 10.1101/gad.13.11.1438
23. C. elegans Sequencing Consortium. Genome sequence of the nematode C. elegans: a platform for investigating 
biology. Science. 282 (5396), 2012-2018 (1998).
84
24. Herman, M. A. Hermaphrodite cell-fate specification. WormBook. 1-16, doi:10.1895/wormbook.1.39.1 (2006).
25. Hobert O. Neurogenesis in the nematode Caenorhabditis elegans (October 4, 2010), WormBook, ed. The C. 
elegans Research Community, WormBook, doi/10.1895/wormbook.1.12.2
26. Brenner, S. The genetics of Caenorhabditis elegans. Genetics. 77 (1), 71-94 (1974). DOI: 
10.1002/cbic.200300625
27. Stiernagle, T. Maintenance of C. elegans. WormBook. 1-11, DOI:10.1895/wormbook.1.101.1 (2006).
28. Murphy, C.T. et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. 
Nature. 424 (6946), 277-284 (2003). DOI: 10.1038/nature01789
29. Klass, M. Aging in the nematode Caenorhabditis elegans: Major biological and environmental factors 
influencing life span. Mechanisms of Ageing and Development. 1977 (6), 413-429 (1977).
30. Cohen, E., Dillin, A. The insulin paradox: Aging, proteotoxicity and neurodegeneration. Nature Reviews 
Neuroscience. 9 (10), 759-767 (2008). DOI: 10.1038/nrn2474
31. Nollen, E. et al. Genome-wide RNA interference screen identifies previously undescribed regulators of 
polyglutamine aggregation. Proceedings of the National Academy of Sciences. 101 (17), 6403-6408 (2004). DOI: 
10.1073/pnas.0307697101
32. Murphy, C.T., Hu, P.J. Insulin/insulin-like growth factor signaling in C. elegans (December 26, 
2013), WormBook, ed. The C. elegans Research Community, WormBook, DOI:/10.1895/wormbook.1.164.1
33. Hung, W., Wang, Y., Chitturi, J., Zhen, M. A Caenorhabditis elegans developmental decision requires insulin
signaling-mediated neuron-intestine communication. Development. 141 (8), 1767-1779 (2014). DOI:
10.1242/dev.103846
34. Pierce, S. et al. Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually 
large and diverse C. elegans insulin gene family. Genes and Development. 15 (6), 672-86 (2001). DOI: 
10.1101/gad.867301
35. Ritter, A., et al. Complex expression dynamics and robustness in C. elegans insulin networks. Genome 
Research. 23 (6), 954-65 (2013). DOI: 10.1101/gr.150466.112
85
36. Matsunaga, Y., Iwasaki, T., Kawano, T. Diverse insulin-like peptides in Caenorhabditis elegans. International 
Biology Review. 1 (1), 1-15 (2017). DOI: 10.18103/ibr.v1i1.1276
37. Li, W., Ruvkun, G. daf-28 encodes a C. elegans insulin superfamily member that is regulated by environmental 
cues and acts in the DAF-2 signaling pathway. Genes and Development. 17 (7), 844-858 (2003). DOI: 
10.1101/gad.1066503
38. Kao, G. et al. ASNA-1 Positively Regulates Insulin Secretion in C. elegans and Mammalian Cells. Cell. 128 (3), 
577-587 (2007). DOI: 10.1016/j.cell.2006.12.031
39. Scerbak, C. et al. Insulin signaling in the aging of healthy and proteotoxically stressed mechanosensory neurons. 
Frontiers in Genetics. 5 (July), 1-14 (2014). DOI: 10.3389/fgene.2014.00212
40. Ward, C., Menting, J.G., Lawrence, M.C. The insulin receptor changes conformation in unforeseen ways on 
ligand binding: Sharpening the picture of insulin receptor activation. Bioessays. 2013 (35), 945-954 (2013) DOI: 
10.1002/bies.201300065
41. Whittaker, L., Hao, C., Fu, W., Whittaker, J. High Affinity Insulin Binding: Insulin Interacts with Two Receptor 
Ligand Binding Sites. Biochemistry. 47 (48), 12900 (2008). DOI: 10.102/bi801693h
42. Duret L., et al. New Insulin-Like Proteins with Atypical Disulfide Bond Pattern Characterized in Caenorhabditis 
elegans by Comparative Sequence Analysis and Homology Modeling. Genome Research. 1998 (8), 348-353 (1998). 
DOI: 10.1101/gr.8.4.348
43. Varewijck, A.J., Janssen, J.A.M.J.L. Insulin and its analogues and their affinities for the IGF1 receptor. 
Endocrine-Related Cancer. 19 (5), F63-F75 (2012). DOI: 10.1530/ERC-12-0026
44. Hung, W. et al. Attenuation of insulin signaling contributes to FSN-1 mediated regulation of synapse 
development. The EMBO journal. 32 (12), 1745-60 (2013). DOI: 10.1038/emboj.2013.91
45. Chen, Z. et al. Two Insulin-like Peptides Antagonistically Regulate Aversive Olfactory Learning in C. elegans. 
Neuron. 77 (3), 572-585 (2013). DOI: 10.1016/j.neuron.2012.11.025
46. Matsunaga, Y., Gengyo-Ando, K., Mitani, S., Iwasaki, T., Kawano, T. Physiological function, expression 
pattern, and transcriptional regulation of a Caenorhabditis elegans insulin-like peptide, INS-18. Biochemical and 
Biophysical Research Communications. 423 (3), 478-83 (2012). DOI: 10.1016/j.bbrc.2012.05.145
86
47. Fernandes de Abreu, D.A. et al. An Insulin-to-Insulin Regulatory network Orchestrates Phenotypic Specificity in 
Development and Physiology. PLOS Genetics. 10 (3), e1004225 (2014). DOI: 10.1371/journal.pgen.1004225
48 Baugh, R.L., Kurhanewicz, N., Sternberg, P.W. Sensitive and Precise Quantification of Insulin-Like mRNA
Expression in Caenorhabditis elegans. PloS one. 6 (3), 18086 (2011). DOI: 10.1371/journal.pone.0018086
49. Chen, Y., Baugh, R. Ins-4 and daf-28 function redundantly to regulate C. elegans L1 arrest. Developmental 
Biology. 394 (2), 314-326 (2014). DOI: 10.1016/j.ydbio.2014.08.002
50. Michaelson, L. C. elegans: A Practical Approach. Ian A. Hope (ed.). Oxford University Press, Oxford. 1999. Pp. 
281. ISBN 0 19 963738 5. Heredity. 85 (1), 97-100 (2000).
51. Chalfie, M., Hart, A. C., Rankin, C. H., Goodman, M. B. Assaying mechanosensation. WormBook. 
DOI:10.1895/wormbook.1.172.1 (2014).
52. Van Raamsdonk, J. M., Hekimi, S. FUdR causes a twofold increase in the lifespan of the mitochondrial mutant 
gas-1. Mechanisms of Ageing Development. 132 (10), 519-521 (2011).
53. Gandhi, S., Santelli, J., Mitchell, D. H., Stiles, J. W., Sanadi, D. R. A simple method for maintaining large, aging 
populations of Caenorhabditis elegans. Mechanisms of Ageing Development. 12 (2), 137-150 (1980).
54. Aitlhadj, L., Sturzenbaum, S. R. The use of FUdR can cause prolonged longevity in mutant nematodes. 
Mechanisms of Ageing and Development. 131 (5), 364-365 (2010).
55. Davies, S. K., Leroi, A. M., Bundy, J. G. Fluorodeoxyuridine affects the identification of metabolic responses to 
daf-2 status in Caenorhabditis elegans. Mechanisms of Ageing Development. 133 (1), 46-49 (2012).
56. Feldman, N., Kosolapov, L., Ben-Zvi, A. Fluorodeoxyuridine improves Caenorhabditis elegans proteostasis 
independent of reproduction onset. PLoS One. 9 (1), e85964 (2014).
57. Pulak, R. Techniques for analysis, sorting, and dispensing of C. elegans on the COPAS flow-sorting system. 
Methods Molecular Biology. 351, 275-286 (2006).
58. Chung, K., Crane, M. M., Lu, H. Automated on-chip rapid microscopy, phenotyping and sorting of C. elegans. 
Nature Methods. 5 (7), 637-643 (2008).
87
59. Hua, Q., et al. A divergent INS protein in Caenorhabditis elegans structurally resembles human insulin and 
activates the human insulin receptor. Genes and Development. 17 (June), 826-831 (2003). DOI: 
10.1101/Gad.1058003
88
